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Schizophrenia patients have altered neuronal connectivity, while the causal factor 
is not fully understood. Most antipsychotic drugs possess dopamine D2 receptor 
(D2R) antagonist property as a therapeutic target for reducing dopamine 
hyperactivity in schizophrenia. It is, however, not known whether the blockage of 
D2R is beneficial to neural connectivity. This study aimed to investigate the 
mechanisms of neurite lesion induced by D2R overactivation and prevention of 
such lesion by changing the D2R downstream signaling.  
Disrupted in schizophrenia 1 (DISC1) is a genetic risk factor for a wide range of 
psychiatric illnesses, including schizophrenia. DISC1 is a multifunctional scaffold 
protein that regulates neurogenesis and neural development in the adult brain. The 
excessive D2R-DISC1 complex is observed in the post-mortem brain of 
schizophrenia patients. However, the role of D2R-DISC1 complex in neurite 
outgrowth is unknown. The aim of Chapter 2 was to study whether neurite lesion 
induced by D2R overactivation is through the D2R-DISC1 complex. This study 
applied fluorescence resonance energy transfer (FRET) technique to quantify the 
interaction between D2R and DISC1 in primary cortical neurons. D2R specific 
agonist quinpirole increased the interaction of D2R and DISC1 by over activating 
D2R in primary cortical neurons. Furthermore, the excessive D2R-DISC1 complex 
reduced glycogen synthase kinase β (GSK-3β) phosphorylation. The increased 
D2R-DISC1 complex formation in conjunction with the decreased GSK-3β 
phosphorylation resulted in neurite impairment of cortical neurons. The 
antipsychotics haloperidol and aripiprazole disrupted the excessive formation of the 
D2R-DISC1 complex caused by D2R overactivation. However, only aripiprazole 
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could reverse the downregulation of phosphorylated GSK3β caused by quinpirole. 
Aripiprazole displayed better preventative effect than haloperidol on neurite lesion 
induced by quinpirole, suggesting that aripiprazole and haloperidol may affect 
neuroplasticity via different signaling pathways. Also, both haloperidol and 
aripiprazole failed to rescue neurite lesion of primary cortical neurons from DISC1 
mutant mice. In summary, the normal D2R-DISC1 complex signaling is critical for 
neurite outgrowth. 
Based on the results that the excessive D2R-DISC1 complex inhibited neurite 
outgrowth, Chapter 3 aimed to determine whether and how the disruption of the 
D2R-DISC1 complex affect the dendritic spines. This part of study applied a cell-
penetrating peptide (TAT-D2pep), which could specifically disrupt the interaction 
of D2R and DISC1 without blocking D2R itself. The super-resolution images 
showed that the D2R-DISC1 complex existed in dendritic spines, neurites, and 
soma of cultured striatal neurons. TAT-D2pep restored neurite length and spine 
density to the normal level by separating the excessive D2R-DISC1 complex in 
neurite and dendritic spines. In addition, this study revealed that uncoupling 
excessive D2R-DISC1 complex could prevent neurite impairment via increasing 
the expression of Neuropeptide-Y (NPY) in striatal interneurons. Taken together, 
this study indicates that TAT-D2pep prevents the synaptic loss caused by the D2R 
overactivation, suggesting that this cell-penetrating peptide is effective in treating 
cognitive deficits in schizophrenia.  
Oxidative stress is reported in the first episode of drug-naïve schizophrenia patients. 
Although D2R hyperfunction is recognized in schizophrenia pathology, the 
relationship between D2R overactivation and oxidative stress is unknown. 
Therefore, Chapter 4 aimed to investigate whether and how D2R overactivation 
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affects mitochondrial reactive oxygen species (ROS) and ROS-mediated 
mitophagy. Firstly, cryo-electron tomography (Cryo-ET) demonstrated that D2R 
overactivation induced by quinpirole damaged cristae in mitochondria of cultured 
striatal neurons. Notably, this study for the first time identifies D2R located on 
neuronal mitochondria. Furthermore, overactivation of the membrane and 
mitochondrial D2R exacerbated oxidative stress with increased ROS and 
malondialdehyde (MDA). In addition, D2R overactivation caused incomplete 
mitophagy. This study revealed that D2R overactivation could induce oxidative 
stress and incomplete mitophagy.  
In conclusion, these studies suggest that the neurite lesion induced D2R 
overactivation is associated with excessive D2R-DISC1 complex formation and 
oxidative stress. Thus, this study provides potential therapeutic targets for 






I would like to express my heartfelt gratitude to Professor Xu-Feng Huang for 
giving me the opportunity to pursue what I am interested in. His patient guidance 
helped me to shape critical thinking skills, a rigorous attitude towards science, and 
academic writing skills. His constant support and encouragement also gave me the 
courage to overcome difficulties during my Ph.D. I would also like to thank my co-
supervisor Dr. Yinghua Yu, who has dedicated her time to provide me detailed 
experimental design. She gave me great support on animal study and Cryo-EM 
project, which brought my research to a new level. 
Furthermore, I would like to thank the China Scholarship Council and the 
University of Wollongong for years of financial support, travel grants. 
I would like to thank Professor Dayong Jin and his fellow Dr. Qian Peter Su in 
School of Mathematical and Physical Sciences Core Member in the University of 
Technology Sydney, for their contribution to resolve protein interaction within 
spines by super-resolution microscopy. I would also like to thank Dr. Juanfang 
Ruan in the Electron Microscope Unit of University of New Sales Wales gave me 
great support in Cryo-EM data analysis.  
My special appreciation to our lab manager Mrs. Hongqin Wang for your great 
supports and guidance not only on my laboratory work but also campus life during 
my candidature. I also hope to thank Ms. Maria Catacouzinos, Ms. Carley Mottley, 
and Mr. Josh Snow for your advice and help through my animal maintenance and 
care; Dr. Qingsheng Zhang and Dr. Tiantian Jin and Dr. Jeremy Lum for your great 
advice for my laboratory techniques.  
Lastly, I would like to thank my father, mother, my wife Zhizhen and my son 
Jihang. Each one of you has played such a crucial role in my life by loving me, 
5 
 
taking care of me and encouraging me. You give me hope in my times of trial, joy 





I, PENG ZHENG, declare that this thesis submitted in fulfilment of the requirements for the 
conferral of the degree Doctor of Philosophy, from the University of Wollongong, is wholly my own 
work unless otherwise referenced or acknowledged. This document has not been submitted for 




















Peng Zheng, Minmin Hu, Yuanyi Xie, Yinghua Yu, Hanna Jaaro-Peled, and Xu-
Feng Huang. "Aripiprazole and haloperidol protect neurite lesions via reducing 
excessive D2R-DISC1 complex formation." Progress in Neuro-
Psychopharmacology and Biological Psychiatry 92 (2019): 59-69. 
Peng Zheng, Qian Peter Su, Dayong Jin, Yinghua Yu, and Xu-Feng Huang. 
"Prevention of Neurite Spine Loss Induced by Dopamine D2 Receptor 
Overactivation in Striatal Neurons." Frontiers in Neuroscience 14 (2020): 642.  
Peng Zheng and Xu-Feng Huang “Activation of Mitochondrial Dopamine D2 
Receptor Inhibits Mitophagy and Causes Schizophrenia-like Behaviors in Mice” 
(Ready for Submission). 
Hu, Minmin, Peng Zheng, Yuanyi Xie, Zehra Boz, Yinghua Yu, Renxian Tang, 
Alison L. Jones, Kuiyang Zheng, and Xu-Feng Huang. "Propionate protects 
haloperidol-induced neurite lesions mediated by neuropeptide Y." Frontiers in 
neuroscience 12 (2018): 743.  
Chen, Xiaoqi, Yinghua Yu, Peng Zheng, Tiantian Jin, Meng He, Mingxuan Zheng, 
Xueqin Song, Alison Jones, and Xu-Feng Huang. "Olanzapine increases AMPK-
NPY orexigenic signaling by disrupting H1R-GHSR1a interaction in the 




Shi, Hongli, Yinghua Yu, Danhong Lin, Peng Zheng, Peng Zhang, Minmin Hu, 
Qiao Wang et al. "β-glucan attenuates cognitive impairment via the gut-brain axis 
in diet-induced obese mice." Microbiome 8, no. 1 (2020): 1-21. 
 
Conference Papers: 
Peng Zheng, Yinghua Yu, Hongqin Wang, Xu-Feng Huang (2016). “D2 Receptor 
hyperactivity increases D2R-DISC1 interaction and impairs neurite growth in the 
prefrontal cortex.” Biological Psychiatry Australia, Newcastle, Australia, P29. 
Peng Zheng, Minmin Hu, Yunayi Xie, Yinghua Yu and Xu-Feng Huang (2017). 
“D2 Receptor hyperactivity increases D2R-DISC1 interaction and impairs neurite 
growth in the prefrontal cortex.”, Biological Psychiatry Australia, Wollongong, 
Australia, P25. 
Oral Presentation: Peng Zheng and Xu-Feng Huang (2018). “Reducing excessive 
D2R-DISC1 complex formation prevents synaptic spine lesion through NPY 
system in striatal neurons” Australasian Neuroscience Society 2018 Annual 






List of Abbreviations 
D2R: dopamine D2 receptor  
DISC1: disrupted in schizophrenia 1  
Akt: protein kinase B  
GSK3β: glycogen synthase kinase 3 beta  
FRET: fluorescence resonance energy transfer  
WT: wild type  
DISC1-LI: DISC1 locus impairment  
MAP-2: microtubule-associated protein 2  
PSD-95: postsynaptic density protein 95  
CaMKII: Ca2+ /calmodulin-dependent protein kinase II  
PBS: phosphate buffered saline  
SDS-PAGE: sodium dodecyl sulphate polyacrylamide gel  
STORM: stochastic optical reconstruction microscopy  
NPY: Neuropeptide Y  
TAT: trans-activating transcriptional activator  
ROS: reactive oxygen species  
Cryo-EM: cryogenic electron microscopy 
MDA: malondialdehyde  
GPCR: G-protein coupled receptors  
ANOVA: one-way analysis of variance 
11 
 
Table of Contents 
 
 
Abstract ............................................................................................................................ 1 
Acknowledgments ........................................................................................................... 4 
Certification ..................................................................................................................... 6 
Publication ....................................................................................................................... 7 
List of Abbreviations .................................................................................................... 10 
Table of Contents ........................................................................................................... 11 
List of Tables, Figures .................................................................................................. 13 
Chapter One ................................................................................................................. 15 
1.1 General Introduction .......................................................................................... 15 
1.2 Literature Review ................................................................................................ 15 
1.2.1 Schizophrenia.................................................................................................. 16 
1.2.2 D2R and Schizophrenia .................................................................................. 16 
1.2.3 D2R and Its Intracellular Signaling ................................................................ 17 
1.2.4 Dual Role of D2R in Neurite Outgrowth ........................................................ 18 
1.2.5 Overactivation of D2R Causes Synaptic Loss ................................................ 19 
1.2.6 Overactivation of D2R Causes Cognitive Decline ......................................... 21 
1.2.7 DISC1 Regulates Neurodevelopment ............................................................. 22 
1.2.8 A Novel Antipsychotic Target: D2R-DISC1 Complex .................................. 23 
1.2.9 GSK-3 Converges D2R and DISC1 Intracellular Signaling Pathway ............ 26 
1.2.10 NPY Modulates Neurite Outgrowth ............................................................. 27 
1.2.11 Mechanism of Haloperidol on Neurite Impairment ...................................... 28 
1.2.12 Mechanism of Aripiprazole on Neuronal Protection .................................... 29 
1.2.13 Super-resolution Technique to Reveal Synaptic Composition ..................... 31 
1.2.14 Schizophrenia and Oxidative Stress ............................................................. 32 
1.2.15 Neurite Lesion induced by D2R Overactivation via Oxidative Stress ......... 33 
1.2.16 Targeting Mitophagy as Novel Strategy for Neurite Deficits ....................... 35 
1.3 Aims and Hypothesis ........................................................................................... 37 
1.3.1 Specific Aims .................................................................................................. 37 
1.3.2 Hypothesis ...................................................................................................... 38 
1.3.3 Significance .................................................................................................... 39 
1.4 General Methods ................................................................................................. 41 
1.4.1 Antibodies and Chemicals .............................................................................. 41 
1.4.2 Cortical and Striatal Neuron Culture .............................................................. 42 
1.4.3 HEK-293 Cell Culture and Transfection ........................................................ 43 
12 
 
1.4.4 Immunofluorescence ....................................................................................... 44 
1.4.5 Fluorescence Resonance Energy Transfer (FRET) ........................................ 45 
1.4.6 Western Blot ................................................................................................... 45 
1.4.7 Super-resolution Imaging of D2R and DISC1 in Dendritic Spines ................ 46 
1.4.8 Cell preparation for cryo-EM ......................................................................... 46 
1.4.9 Image acquisition by Cryo-electron microscopy ............................................ 47 
1.4.10 Statistical analysis ......................................................................................... 47 
1.5 Overview of the Thesis ........................................................................................ 48 
1.5.1 Aripiprazole and haloperidol protect neurite lesions via reducing excessive 
D2R-DISC1 complex formation .............................................................................. 49 
1.5.2 Prevention of Neurite Spine Loss Induced by Dopamine D2 Receptor 
Overactivation in Striatal Neurons .......................................................................... 50 
1.5.3 Overactivation of Mitochondrial Dopamine D2 Receptor Inhibits Mitophagy 
and Causes Schizophrenia-like Behaviors in Mice .................................................. 51 
1.5.4 Summary ......................................................................................................... 52 
Chapter Two ................................................................................................................. 54 
Aripiprazole and Haloperidol Protect Neurite Lesions via Reducing Excessive 
D2R-DISC1 Complex Formation ............................................................................. 54 
Chapter Three .............................................................................................................. 71 
Prevention of Neurite Spine Loss Induced by Dopamine D2 Receptor 
Overactivation in Striatal Neurons .......................................................................... 71 
Chapter Four ................................................................................................................ 87 
Overactivation of Mitochondrial Dopamine D2 Receptor Inhibits Mitophagy ...... 87 
Chapter Five ............................................................................................................... 117 
5.1 Overall Discussion and Conclusions ................................................................ 117 
5.1 Recommendations for Future Research .......................................................... 140 
5.2 Conclusion .......................................................................................................... 142 





List of Figures  
 
Figure 1.1: Diagram of the human D2R sequence……………………………….25 
Figure 5.1: Proposed mechanisms of D2R-DISC1 induced neurite impairment in 
cultured cortical neurons………………………………………………………..132 
Figure 5.2: Proposed mechanisms of D2R-DISC1 induced neurite impairment in 
cultured striatal neurons………………………………………………………...136 
Figure 5.3: TAT-D2pep reverses the reductions of synaptic proteins and autophagy 





List of Tables 
Table 5.1： Summary of main findings in cortical neurons………………..…..119 
Table 5.2： Summary of main findings in striatal neurons…………..…………120 






1.1 General Introduction 
Schizophrenia is a devastating mental illness that influences thought and behavior 
(Howes et al., 2016). Neuroimaging findings have revealed that neurite deficits are 
associated with cognitive symptoms in schizophrenia (Rae et al., 2017). The 
hyperactivity of striatal D2R is predominantly responsible for psychosis in 
schizophrenia, which leads the current antipsychotics to block D2R (Howes and 
Kapur, 2009). However, the clinicians and researchers raise concerns about the 
potential risks of antipsychotic side-effects due to the complete blockade of D2R. 
Thus, there is a high urgency to understand the mechanism of D2R overactivation 
induced neurite deficits. Although cAMP-dependent and β-arrestin independent 
signaling pathways of D2R have been acknowledged as the principal downstream, 
the exact mechanism is still largely unknown, especially for several identified D2R-
heterocomplex. Furthermore, oxidative stress has recently been determined in the 
first episode of drug-naïve schizophrenia patients with cognitive deficits (Solberg 
et al., 2019, Xie et al., 2019). Therefore, D2R overactivation may regulate different 
signaling pathways to affect neuroplasticity in the brain. The present series of Ph.D. 
studies are designed to elucidate the mechanism of D2R overactivation in neurite 
impairment and then discover proper atypical antipsychotics and cell-penetrating 
peptides to prevent neurite lesions. A better understanding of these mechanisms 
will help the development of new antipsychotic drugs to ameliorate neurite 
impairment and oxidative stress with fewer side-effects for schizophrenia patients. 




Schizophrenia is a severe brain disorder that significantly impairs normal brain 
function and the patients' response to reality (Karl and Arnold, 2014). There are 
approximately 20 million people worldwide suffering schizophrenia at present 
(Disease et al., 2018). Schizophrenia usually occurs in adolescent period and lasts 
for a lifetime (Gomes et al., 2016). The symptoms of schizophrenia consisting of 
positive symptoms such as delusions, hallucinations, negative symptoms such as 
emotional flattening, social isolation, and cognitive symptoms such as learning 
difficulties (Mueser et al., 2013). The actual pathology of schizophrenia remains to 
be elucidated. Antipsychotic drugs are primary medications for treating 
schizophrenia and other psychiatric disorders. If the patients suffer the first episode 
of schizophrenia, the antipsychotics might treat them effectively (Girgis et al., 
2011). However, the absence of response to antipsychotics in certain patients and 
their various side-effects, urging researchers to search for a better treatment for 
schizophrenia.  
1.2.2 D2R and Schizophrenia  
The onset of psychotic symptoms is strongly associated with alterations in 
dopamine function (Kesby et al., 2018). For healthy people, psychotic symptoms 
can be induced by dopamine stimulants such as amphetamine. Positron emission 
tomography findings report that elevated dopamine synthesis capacity and release 
are observed in the striatum of schizophrenia patients compared with healthy 
subjects (Howes et al., 2009). Alterations in dopaminergic function within the brain 
are considered as a critical factor of psychotic symptoms (Winton-Brown et al., 
2014). Thus, striatal D2R antagonism is a general pharmacodynamic property of all 
current antipsychotics, which further supports that D2R hyperactivity is a core 
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target for schizophrenia treatment (Urs et al., 2017). It is revealed that most 
antipsychotics bind to D2R, but not D1R, and that blocking D2R is enough to inhibit 
hyperdopaminergic activity (Beaulieu and Gainetdinov, 2011). Clinical studies 
have confirmed that hyperdopaminergic activity occurs before the onset of 
psychosis in schizophrenia, suggesting that the dysfunction of the dopaminergic 
system is not the consequence of antipsychotic exposure or psychosis (Brisch et al., 
2014). Further, the occupancy of D2R above 80% could not only increase the risk 
of cognitive decline but also extrapyramidal side effects (Sakurai et al., 2013).  
Antipsychotic drug can cause extrapyramidal syndrome (EPS) including dystonia, 
parkinsonism, and tardive dyskinesia. Thus, the evidence strongly supports that 
D2R activity plays an essential role in psychosis.  
1.2.3 D2R and Its Intracellular Signaling 
The neurotransmitter dopamine belongs to the catecholamine family, having 
various critical functional roles in humans, such as the regulation of voluntary 
motor activity, cognition, and reward pathways (Kapur and Marques, 2016). The 
effects of dopamine are mediated through five subtypes of dopamine receptors, D1 
to D5. The dopamine D1-like receptor subtypes include the dopamine D1 and D5 
receptors, whereas the D2-like receptor subtypes consist of dopamine D2, D3, and 
D4 receptors (Rangel-Barajas et al., 2015). Generally, the D1R and D2R distribute 
more widely than the D3R, D4R, and D5R in the brain (Hurley and Jenner, 2006, 
De Mei et al., 2009). There are two major D2R alternatively spliced isoforms, D2R-
long isoform (D2RL) and D2R-short isoform (D2RS), which are distinguished by 
the additional 29 amino acids of the third intracellular loop (ICL3) (Giros et al., 
1989). It has been reported that D2RL majorly represents in postsynapse, while 
D2RS expresses in pre-synapse and is associated with auto-receptor functions (De 
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Mei et al., 2009). The D2R is richly expressed in the striatum, nucleus accumbens, 
and frontal cortex. Further, D2R is also shown in the ventral tegmental area, 
hypothalamus, and hippocampus (Seeman, 2006).  
D2R is a G protein-coupled receptor (GPCR) that activates both G protein-
dependent signaling and non-G protein cascades (Beaulieu et al., 2009). Activation 
of the D2R can inhibit the activity of adenylyl cyclase after it couples to Gαi 
proteins (Bergson et al., 2003). D2R is also demonstrated to modulate other second 
messengers, including inositol phospholipid, arachidonic acid, potassium, and 
calcium currents (Missale et al., 1998). Notably, D2R can function not only through 
cAMP levels but also through the noncanonical Akt-GSK3 signaling cascade 
triggering by recruiting β-arrestin proteins (Beaulieu et al., 2005, Beaulieu et al., 
2007). Thus, it is crucial to study which one of D2R signaling pathways is targeted 
by antipsychotic drugs.  
1.2.4 Dual Role of D2R in Neurite Outgrowth 
Neuronal development involves morphological alterations of neurite to become 
functional axons and dendrites (Ronan et al., 2013). Dopamine and its D2R are 
associated with neuronal development. Researchers started to investigate the effects 
of D2R activation on neurite outgrowth from dopamine. Decades ago, dopamine 
was firstly reported to elongate neurite through activating D2R in embryonic rat 
cortical neurons (Reinoso et al., 1996). Later, some researchers performed studies 
to investigate the outcomes of modulating D2R activity on neuronal morphology in 
vitro and in vivo. Cortical neuroplasticity is found to be another target of 
antipsychotics by blocking D2R activity (Rangel-Barajas et al., 2015). Todd et al. 
firstly reported treatment with 10 to 1000 nM quinpirole resulted in small increases 
in the average length of neurites in primary cortical neurons. The effects on 
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branching did not reach statistical significance. These two morphogenic effects 
were blocked by D2R antagonists eticlopride and spiperone, suggesting a low 
concentration of quinpirole promotes neurite growth via D2R (Todd, 1992). 
Following this critical finding, Todd's group transfected D2-like receptors (D2, D3 
and D4) into the dopaminergic mesencephalic cell line MN9D, which confirmed 
the role of D2R overexpression in inhibiting neurite outgrowth (Swarzenski et al., 
1994). At that time, psychiatric disorders are considered that the dopaminergic 
pathways are overactive (Seeman, 1987). Thus, researchers are interested in 
whether D2R overactivation will alter the neuronal morphology. Reinoso et al. 
reported that quinpirole at 1 µM promotes neurite outgrowth, which is consistent 
with previous findings. However, they also firstly demonstrated that quinpirole at 
100 µM significantly inhibited neurite length and branch of cultured rat cortical 
neurons (Reinoso et al., 1996). Previous researches suggest that D2R plays a role 
in neuronal differentiation and neurogenesis. Combined with previous clinical 
research, this finding links the D2R overactivation to neuronal impairment and 
cognitive decline in psychiatric disorders. Therefore, this thesis aimed to 
investigate the mechanism underlying neuronal impairment caused by D2R 
overactivation.  
1.2.5 Overactivation of D2R Causes Synaptic Loss 
The synaptic reduction is the critical pathology in schizophrenia. The two well-
established observations support this opinion. First, the progressive loss of gray 
matter was observed in patients at the time of disease onset (Vita et al., 2012). 
Second, significant reductions in the density of dendritic spines on pyramidal 
neurons of schizophrenia patients were observed (Moyer et al., 2015). A recent 
study revealed that dendritic spines with smaller volumes were significantly lost in 
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the post-mortem brain of schizophrenia patients, suggesting the inhibition of 
synaptogenesis exists in schizophrenia (MacDonald et al., 2017). Importantly, 
previous findings demonstrated that the synaptic loss in the prefrontal cortex is not 
the consequence of treatment with antipsychotic medications (Glantz and Lewis, 
2000). Animal studies offer in vivo evidence to reveal the importance of D2R in 
regulating dendritic spines. Chronic treatment with a selective D2R agonist PPHT 
decreased the spine density of cortical pyramidal neurons without affecting 
GABAergic interneurons. D2R may directly mediate the inhibition of dendritic 
spines by PPHT existed in pyramidal neurons, but also indirectly through D2R of 
interneurons (Castillo-Gomez et al., 2016). However, another study shows that 
quinpirole increased the dendritic spine density in hippocampal neurons, suggesting 
that the effects of D2R on the dendritic spine could also be concentration-
dependent. Jia et al. thoroughly investigated the function of D2R in dendritic spine 
morphogenesis by using pharmacologic and genetic approaches (Jia et al., 2013). 
The dendritic spine density of hippocampal neurons was significantly reduced after 
male mice were intraperitoneally injected with D2R agonists quinpirole and 
bromocriptine. Continuous injection of eticlopride remarkably enhanced the spine 
density, whereas the single injection failed to do so. Interestingly, D1R is not 
involved in regulating hippocampal spine development. Besides, overexpression of 
D2R reduced the spine density of CA1 hippocampal neurons, whereas knockdown 
of D2R increased it (Jia et al., 2013).   
It is believed that the abnormal neurodevelopment in schizophrenia can lead to 
improper function of synaptic communication (Harrison and Weinberger, 2005). A 
variety of proteins exists in synapses, which have been used as biomarkers of 
synaptic connection. Synaptophysin is widely used as the marker of presynapse, 
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which can also indicate neuronal synaptic density (Okabe et al., 2001). The 
expression of synaptophysin in the cortex is significantly declined in patients with 
schizophrenia (Osimo et al., 2019). PSD-95 is abundant in the brain and 
concentrated in the postsynaptic density. In human post-mortem studies, PSD-95 
expressed at a relatively low level in brain regions, which may be associated with 
cognitive decline in schizophrenia (de Bartolomeis et al., 2014). Another post-
mortem study reported that adolescent schizophrenia patients had reduced 
expression of PSD-95 protein in the thalamus and hippocampus (Clinton and 
Meador-Woodruff, 2004, Toro and Deakin, 2005). PSD-95 was reported to interact 
with other synaptic proteins, such as DISC1, in the development of excitatory 
synapses as well as in regulating synaptic strength and plasticity (Seshadri et al., 
2015). Taken together, it is important to investigate the mechanisms underlying the 
inhibitory effects of D2R overactivation on synapse in this thesis.   
1.2.6 Overactivation of D2R Causes Cognitive Decline 
The neurocognitive decline is a core feature in schizophrenia patients (Simpson et 
al., 2010). Accumulating evidence has shown that the dopaminergic system in the 
central nervous is profoundly associated with cognition. Using single-photon 
computerized emission tomography, Abi-Dargham et al. found that the increased 
occupancy of striatal D2 receptors by dopamine occurs in first-episode drug-naive 
patients. Notably, the occupancy of striatal D2R is not statistically different 
between drug-naïve and previously treated patients (Kegeles et al., 2008). Thus, the 
increased activation of D2 receptors by dopamine observed in schizophrenia 
patients is present at the onset of illness and not a consequence of antipsychotic 
treatment. A recent study reported that decreased D2R occupancy by aripiprazole 
intervention contributed to cognitive improvement in schizophrenia patients (Shin 
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et al., 2018). To further investigate the role of D2R in specific aspects of cognition, 
a murine model of schizophrenia was generated featuring with D2R 
overexpression. Mice overexpressing D2R in the striatum displayed a significant 
deficit in working memory instead of a general cognitive deficit (Kellendonk et al., 
2006). However, whether or not there is an impaired working memory caused by 
D2R overactivation in adolescence is still unknown.  
1.2.7 DISC1 Regulates Neurodevelopment 
Among all potential candidate genes, DISC1 is considered as one of the most 
convincing risk factors for major mental disorders. Initial evidence for the 
involvement of the DISC1 gene in schizophrenia is mainly based on a large Scottish 
pedigree where the gene is disrupted by a chromosomal translocation (Millar et al., 
2000). There are two remarkable expression peaks of DISC1 during neurogenesis 
in the developing mouse brain, suggesting that its crucial role in neurodevelopment 
(Schurov et al., 2004). The pathology of DISC1-related psychiatric disorders is 
because of an altered interaction between DISC1 and other proteins. Therefore, 
identifying the novel interactors with DISC1 will be of great importance in 
understanding the therapeutic target for treating schizophrenia. 
The researchers have demonstrated that DISC1 plays an essential role in neuronal 
development and maturation by utilizing the DISC1 mutation mice model. In the 
DISC1 transgenic model, mice have shown schizophrenia-like phenotypes, 
including deliberated neuronal morphology, lowered neuron density, diminished 
neurogenesis, and reduced striatal volumes (Clapcote et al., 2007, Lee et al., 2011).  
In human brains, DISC1 has a robust modulatory effect on cortical development 
and increases the thickness of the prefrontal cortex (Carless et al., 2011). Seeman 
proposed that D2R is in a high-affinity state (D2Rhigh) in schizophrenia, suggesting 
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the activity of D2R could be the target for treatment instead of blocking the D2R 
(Seeman et al., 2006). Results from the animal research exhibited that DISC1 can 
increase the proportion of D2Rhigh in the striatum, which led to the status of 
dopamine hyperactivity (Jaaro-Peled et al., 2013). In addition, it was reported that 
DISC1 dysfunction increased dopamine receptors in the striatum without altering 
the dopamine level in the DISC1-L100P mutant (Clapcote et al., 2007).  
DISC1 contributes to the proliferation of neural progenitors through the interaction 
with GSK3 and, in turn, regulation of β-catenin activity (Mao et al., 2009, Singh et 
al., 2011). DISC1 directly inhibited GSK3β activity, which prevented the 
phosphorylation and degradation of β-catenin (Mao et al., 2009). Furthermore, 
knockdown of DISC1 inhibited progenitor proliferation, which is likely through 
exiting the premature cell cycle. These effects could be restored by overexpression 
of β-catenin or reducing GSK3β activity (Mao et al., 2009, Singh et al., 2011).  
DISC1 is mainly located in dendritic spines in which relates to the synaptic 
architecture (Hayashi-Takagi et al., 2010). In the mature mouse brain, DISC1 
determines the development of functional synapses and the rate of transduction of 
intrinsic excitability (Kim et al., 2012). Besides, DISC1 mice with point mutant on 
Gln31Leu and Leu100Pro showed a significantly decreased spine density (Lipina 
et al., 2013), indicating that synapse alternation may link to their behavioral 
phenotypes. This study aimed to reveal how the DISC1 would interact with its 
associated proteins in the synapse to regulate dendritic spine formation.   
1.2.8 A Novel Antipsychotic Target: D2R-DISC1 Complex 
Accumulating data indicate that D2R is a hub receptor that interacts not only with 
many G protein-coupled receptors but also with scaffolding proteins (Bradshaw 
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and Porteous, 2012). One emerging new concept in neuropsychopharmacology is a 
dysfunction of D2R complexes contributing to the development of schizophrenia. 
The role of D2R in schizophrenia pathology has altered with the discovery of 
various D2R complexes in the brain. These D2R complexes may offer novel targets 
for antipsychotic drugs and provide better therapeutic outcomes.  
Recent research showed the hyperdopaminergic status induces an increase of D2R-
DISC1 complex, and this complex is also found in the post-mortem brain from 
schizophrenia patients and mouse models of schizophrenia (Su et al., 2014). Based 
on these findings, a new compound targeted on interfering D2R-DISC1 interaction 
with less antipsychotic-like side effects is synthesized (Su et al., 2014). The 
achievement of antipsychotic-like outcomes only needs interrupting the interaction 
between D2R and DISC1 without blocking D2R completely. The D2R-DISC1 
complex is an important finding because it narrows down the targets of 
antipsychotics, which may avoid side-effects. However, whether the D2R-DISC1 
complex plays a role in neuroplasticity is unclear, which will be investigated in this 
study. Furthermore, it will be essential to identify the location of the D2R-DISC1 
complex in neurons by using high-resolution microscopy. Dysfunction of the 
scaffolding protein can cause alternations of protein complexes. Thus, this study 
also utilizes DISC1-LI mice, which diminishes the D2R-DISC1 binding site, to 






Figure 1.1 Diagram of the human D2R sequence. Sequence highlighted with red 
represents D2R-DISC1 interacting site (211aa-225aa). TAT-D2pep will bind to the 
D2R-DISC1 interacting site to separate the D2R-DISC1 complex. Sequence 
highlighted with blue represents the difference between D2R long isoform and D2R 
short isoform. It illustrates that both D2R long isoform and D2R short isoform can 
interact with DISC1. Abbreviation: ECL: extracellular loop; ICL: intracellular loop; 
TM: transmembrane.  
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1.2.9 GSK-3 Converges D2R and DISC1 Intracellular Signaling Pathway 
Several studies have implicated that GSK-3β is associated with the symptoms of 
neuropsychiatric disorders like schizophrenia (Lovestone et al., 2007). The 
phosphorylation of GSK-3β on serine 9 indicates the inhibited activity of GSK-3 
(Grimes and Jope, 2001). Recent studies have shown that not only atypical 
antipsychotics but also typical antipsychotics increases the phosphorylation of 
GSK-3α and GSK-3β by either activating Akt or mimic Akt activity (Li and Xu, 
2007, Park et al., 2011a). It is indicated that cAMP levels in neurons do not regulate 
the effect of D2R on GSK-3β activity. Instead, it is modulated by a multifunctional 
scaffolding protein β-arrestin, which is known to be responsible for G protein-
coupled receptor internalization (Beaulieu et al., 2007). The D1R agonist 
SKF38393 does not alter GSK-3β phosphorylation at serine 9, suggesting that 
GSK-3β phosphorylation may be regulated explicitly by D2R (Lebel et al., 2009).  
The regulation of D2R on GSK-3 is further determined by using D2R knockout 
mice. The absence of hippocampal D2R leads to neuronal apoptosis by increasing 
the activity of  GSK-3β in the mice (Tripathi et al., 2010). D2R knockout mice 
showed delays in movement initiation and inhibition in total locomotor activity, 
implicating that the abnormal behavior induced by D2R may arise through GSK-3 
activation (Kelly et al., 1998). There were no significant increases in 
phosphorylated CaMKIIα in neurons of nucleus accumbens shell and caudate 
nucleus of D2 knockout mice, suggesting that calcium signaling cascade was not 
involved in D2R signaling pathway (Rashid et al., 2007).  
DISC1 is shown to determine the proliferation and fate of neural progenitors 
through interaction with GSK-3 and regulation of β-catenin activity (Mao et al., 
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2009, Singh et al., 2011). DISC1 directly inhibits GSK-3β activity, which prevents 
the phosphorylation and degradation of β-catenin (Mao et al., 2009). Knocking 
down DISC1 gene expression inhibits neuronal progenitor proliferation while over-
expression of DISC1 rescues neurodevelopment in the developing cortex (Niwa et 
al., 2010). The inhibited neuronal proliferation can also be restored by over-
expression of β-catenin or inhibiting GSK-3β activity (Mao et al., 2009, Singh et 
al., 2011). Furthermore, reduced progenitor proliferation is possibly due to exiting 
the premature cell cycle. In addition, the enhanced occupancy of D2R was observed 
in the striatum of DISC1 mutant (dominant-negative) mice, suggesting that the 
activation of GSK-3β induced by dysfunctional DISC1 may be through D2R 
overactivation (Jaaro-Peled et al., 2013).  
Although GSK-3β knockout mice could die in utero, GSK-3β heterozygous 
knockout mice are viable and display decreases in exploratory activity and reduced 
locomotor activity to amphetamine (Urs et al., 2012). GSK-3α knockout mice are 
viable and exhibited a reduction in locomotion to a new environment and impaired 
sensorimotor gating (Kaidanovich-Beilin et al., 2009). Because GSK3β signaling 
is vital in promoting neurite outgrowth and activated GSK3β is associated with the 
development of psychosis, it is assumed that the GSK3β signaling pathway is 
involved in the D2R-DISC1 complex intracellular signaling (Beurel et al., 2015). 
1.2.10 NPY Modulates Neurite Outgrowth 
Neuropeptide Y (NPY) is a vital neuromodulator which is richly existed in the 
central nervous system (Gotzsche and Woldbye, 2016). More recently, we 
addressed the question of whether NPY is involved in the haloperidol-induced 
neuronal impairment. In our laboratory, it was found that the downregulation of 
NPY caused by haloperidol results in dendritic spine loss and neuronal damage in 
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primary striatal neurons. The short-chain fatty acid propionate protected against 
neuronal lesions by upregulating the NPY level (Hu et al., 2018). Treatment with 
quinpirole or amphetamine decreased NPY expression by overactivation of D2R in 
mice (Kuo, 2003). Previously, Hansel et al. revealed that NPY is identified in the 
immature neurons and precursor cells of the rat brain, suggesting its function in 
neurogenesis (Hansel et al., 2001). NPY-deficient mice contain about 25% fewer 
neurons than wild type mice, indicating loss of NPY in vivo inhibits the 
development of neuronal progenitors (Hansel et al., 2001). Accumulating pieces of 
evidence regarding the study of striatal NPY indicated that the existence of a 
possible reciprocal relationship between D2R and NPY. This study aimed to 
investigate the effect of D2R-DISC1 complexes on NPY.  
1.2.11 Mechanism of Haloperidol on Neurite Impairment 
Antipsychotic drug modulates dysfunction in neurotransmission, which plays an 
important role in reducing the symptoms of schizophrenia (Huang and Song, 2019). 
Substantial evidence has suggested that neuronal plasticity exhibited by neurite 
outgrowth and neuroprotection underlies the therapeutic effects of atypical 
antipsychotic drugs (Lieberman et al., 2008, Molteni et al., 2009). As a 
representative first-generation antipsychotic drug (FGA), haloperidol antagonizes 
D2R to reduce positive symptoms with little effect on cognitive improvement 
(Harvey et al., 2005). Further, the neurotoxic effects of haloperidol have been 
reported to cause side effects, including extrapyramidal symptoms and tardive 
dyskinesia (Rasmussen et al., 2017). The blockade of striatal D2R is believed to be 
responsible for haloperidol drawbacks (Kapur et al., 2000). So far, the effect of 
neurotoxicity of haloperidol has been compared with several second-generation 
antipsychotic drugs. Haloperidol has neurotoxicity in SH-SY5Y cells by increasing 
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caspase-3 activity (Gasso et al., 2012). Our group recently reported that haloperidol 
impaired neurite growth of human SH-SY5Y neurons and primary striatal neurons 
through down-regulating NPY expression (Hu et al., 2018). Notably, we found that 
haloperidol prevented the reduction of neurite length induced by D2R 
overactivation but no change in the number of branching in primary cortical 
neurons. Haloperidol had no significant effects on reversing synaptophysin and 
PSD-95 expression in the cortical neurons treated with quinpirole (Zheng et al., 
2018). It has been demonstrated that haloperidol had no effects on promoting 
neurite growth and upregulating synaptic proteins compared with amisulpride, 
which is an atypical antipsychotic drug. They demonstrated that haloperidol failed 
to protect neuronal morphology mainly because it does alter BDNF expression and 
GSK-3β phosphorylation in human neuroblastoma cells (Park et al., 2011b). Other 
researchers found that haloperidol decreases the synaptophysin expression in the 
rat hippocampus (Lieberman et al., 2008). However, the expression of 
synaptophysin was not significantly changed in the primate cerebral cortex (Lidow 
et al., 2001). Thus, it is imperative to investigate why haloperidol cannot protect 
neurite and improve cognition in this thesis.  
1.2.12 Mechanism of Aripiprazole on Neuronal Protection 
Binding to D2R is considered as a necessary action for current antipsychotic drugs 
(Kapur et al., 2000). However, there is a clear distinction in the D2R binding 
affinity between FGAs and second-generation antipsychotics (SGAs). FGAs 
majorly antagonize D2R, while SGAs can bind to other membrane receptors with 
less D2R occupancy (Lieberman et al., 2008). Moreover, the pharmacological 
findings of aripiprazole have changed the understanding of antipsychotic action on 
dopamine receptors. Research on aripiprazole provides a clinically relevant 
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mechanism according to D2R occupancy instead of the D2R blockade. Depending 
on endogenous dopamine levels, aripiprazole may act as a full antagonist or a 
partial agonist on D2R (de Bartolomeis et al., 2015). Unlike FGAs, aripiprazole is 
effective in reducing positive symptoms and improving cognitive function (Kumar 
et al., 2017). More importantly, aripiprazole may pose a lower risk of 
extrapyramidal symptoms and relapse (Kane et al., 2007, Kane et al., 2002). 
Compared with haloperidol, aripiprazole is clinically proven to have superior 
efficacy and safety in the treatment of early-stage schizophrenia (Girgis et al., 
2011). Besides, several pharmacological studies have revealed that aripiprazole 
possesses neuroprotective features. We report that aripiprazole ameliorates neurite 
impairment caused by D2R overactivation in cultured cortical neurons (Zheng et 
al., 2018). Ishima et al. also found that aripiprazole potentiates NGF-induced 
neurite outgrowth of PC 12 cells (Ishima et al., 2012). Similar to aripiprazole, 
another D2R partial agonist brexpiprazole is also reported to promote neurite 
outgrowth in conjunction with NGF in PC 12 cells, suggesting that the property of 
agonism could contribute to neuroplasticity (Ishima et al., 2015). Aripiprazole 
protects dopaminergic neurons against glutamate cytotoxicity, which can be 
blocked by D2R antagonist sulpiride (Matsuo et al., 2010). Aripiprazole is also 
reported to prevent synaptic loss, which is associated with the treatment of 
pathology of schizophrenia (Glausier and Lewis 2013). Compared with haloperidol 
treatment, the administration of aripiprazole significantly increases dendritic spine 
density with a rise in postsynaptic puncta (Takaki et al., 2018). Several pieces of 
research have contemporarily highlighted that the neuroprotective effect of 
aripiprazole is mediated by Akt-GSK3 signaling cascade (Pan et al., 2016, Takaki 
et al., 2018, Park et al., 2009). Although some atypical antipsychotic drugs, like 
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olanzapine or ziprasidone, have been revealed to promote neurite outgrowth 
through upregulating synaptophysin and PSD-95 expression, the investigation of 
aripiprazole on these synaptic proteins has not yet been performed. Since 
aripiprazole acts as a partial agonist of D2R, it is necessary to investigate whether 
the D2R-DISC1 complex and its downstream signaling pathway are affected by 
aripiprazole.   
1.2.13 Super-resolution Technique to Reveal Synaptic Composition 
Stochastic Optical Reconstruction Microscopy (STORM) is one of the most 
commonly used types of super-resolution microscopy. STORM has made it 
possible to break the diffraction barrier and reveal objects as small as 10-20 nm 
(Bates et al., 2013). Particularly exciting is the possibility of imaging the very early 
stages of spine formation and subsequent maturation, which has not been possible 
to study with conventional light microscopy. Additionally, the molecular 
composition and organization of synapses are essential for synaptic plasticity. The 
enhanced resolution of STORM permits a more precise analysis of protein 
localization and interaction within individual spines and synapses (Rust et al., 2006, 
Hruska et al., 2018). Previous research using the STORM technique has reported 
that clozapine may restore dendritic spine density by changing the number of D2R 
nanoclusters in the striatum of the mice model mimicking schizophrenia (Onishi et 
al., 2018). Our preliminary research showed that D2R activity is vital to strengthen 
synaptic plasticity (Hu et al., 2018, Zheng et al., 2018). However, we were unable 
to observe and quantify D2R within synapse due to a lack of nanoscale microscopy. 
Interestingly, a recent study reported that as the size of a dendritic spine increases, 
there is a net increase in the amount of PSD-95 and synaptophysin found in a single 
dendritic spine (Hruska et al., 2018). So far, it has not been revealed how the D2R 
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interacts with DISC1 in a single synapse. By applying STORM to observe dendritic 
spines of cultured neurons, this study aimed to study the interaction of D2R and 
DISC1 and its effects on synaptic connections from a nanoscale perspective.  
1.2.14 Schizophrenia and Oxidative Stress 
The brain is particularly vulnerable to oxidative damage (Gandhi and Abramov, 
2012). Clinical data indicated that the risk factors converge upon oxidative stress 
in schizophrenia patients (Koga et al., 2016). The occurrence of oxidative stress 
adversely impacts the developmental brain, which is relevant to the development 
of schizophrenia. Oxidative stress occurs when there is an overproduction of 
reactive oxygen species. The oxidative stress in schizophrenia leads to 
mitochondrial damage, which drives mitochondria to produce more oxidants 
(Rajasekaran et al., 2015). Several studies have demonstrated that mitochondrial 
malfunction can lead to cellular degeneration (Dias et al., 2013). The degeneration 
is because the peroxidation of membrane lipids produces toxic aldehydes, which 
can impair critical mitochondrial enzymes (Murphy, 2009). Notably, a study using 
a combined transcriptomic, proteomic, metabolic approach found that altered 
proteins in schizophrenia patients are associated with mitochondrial function and 
oxidative stress responses (Prabakaran et al., 2004). Abnormal mitochondrial 
morphology, size, and density have been reported in the brains of schizophrenia 
individuals (Ben-Shachar, 2002). An increased level of oxidative stress was 
reported in the first episode of drug-naïve schizophrenia patients with cognitive 
deficits (Solberg et al., 2019, Xie et al., 2019). Clinical study also showed an 
increased lipid peroxidation, particularly in first-episode drug naïve patients with 
schizophrenia (Jordan et al., 2018). Ketamine and phencyclidine are often used to 
induce psychotic symptoms. These psychostimulants increase the ROS as part of 
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their mechanism of action (Kovacic and Cooksy, 2005). When the ROS inhibitor 
NAC was given to schizophrenia patients, it ameliorated the symptoms even in 
treatment-resistant patients (Zhang and Yao, 2013). Thus, ample evidence suggests 
a vital role for oxidative stress in the pathogenesis and progression of 
schizophrenia.  
1.2.15 Neurite Lesion Induced by D2R Overactivation via Oxidative Stress 
Neurons are well-known to be vulnerable to ROS-induced damage. ROS causes 
neurite lesions before the induction of cell death (Fukui, 2016). Neuron produces 
ROS at multiple organelles. Among these sites, mitochondria contribute to the most 
substantial amount of ROS. The production of mitochondrial ROS is primarily 
through the release of superoxide at complexes I and III of the mitochondrial 
respiratory chain (Murphy, 2009). Thus, mitochondrial integrity is essential for 
maintaining normal ROS level and neuronal morphology. Mitochondrial injury has 
been documented to result in neurite impairment. Firstly, mitochondrial integrity is 
fundamental to the formation of the neural network. Fragmented mitochondria and 
distorted cristae enhance mitochondrial ROS formation, reduce ATP levels, and 
show a severely disrupted neural network (Ganjam et al., 2019). Permeabilization 
of the mitochondrial membrane significantly upsurges oxidative stress, followed by 
the loss of hippocampal neurons in mice (Merkwirth et al., 2012). Secondly, the 
amount of mitochondrial is associated with neurite outgrowth. 
Immunocytochemistry results showed that the growing neurite of cortical neurons 
contains more active mitochondria, especially at the terminal of neurite (Trigo et 
al., 2019). Recent research revealed that excessive mitochondrial ROS production 
decreases mitochondrial number and motility, followed by neurite impairment in 
M17 human neuroblastoma cells (Parrado-Fernandez et al., 2018). Although 
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conventional electron microscopy provides us strong evidence about the alternation 
of mitochondria in neuronal impairment, the sample preparation is redundant, and 
sometimes it can cause structural damage. Using cryo-electron tomography (cryo-
ET), this study aimed to examine whether D2R overactivation would cause neurite 
lesion through affecting mitochondrial in native environments within axons and 
synaptic vesicles of primary neurons.  
A wide range of studies has reported that ROS inhibits neurite outgrowth. 
Excessive ROS production significantly decreases the percentage of cells with 
neurite outgrowth to 5% within 24 hours in N2a cells (Wang et al., 2010). Damaged 
neurites of N2a cells tend to become bead-shaped or fragmented (Fukui, 2016). The 
ROS specific inhibitor NAC blocks the axonal lesion caused by oxidative stress 
(Hervera et al., 2018). NAC can inhibit nerve growth factor-induced neurite 
outgrowth of PC12 cells by decreasing ROS amount, suggesting the dual role of 
ROS on neurites (Zhou and Too, 2011, Suzukawa et al., 2000). In addition, a high 
level of ROS significantly decreases the density of the dendritic spine, which has 
been documented in patients, animal models and cell models (Massaad and Klann, 
2011). Thus, the effect of ROS on neurite outgrowth still requires further 
investigation.   
The role of D2R in regulating ROS is debatable. Accumulating evidence showed 
that excessive endogenous or exogenous dopamine increased ROS production in 
the brain (Delcambre et al., 2016). The excessive ROS production induced by 
dopamine could cause cell death in SH-SY5Y cell line (Gomez-Santos et al., 2003). 
The early study revealed that primary cortical neurons treated with dopamine had 
significantly increased ROS production, which was blocked by D2R antagonists 
(Grima, 2003, Acquier et al., 2013). Blocking ROS production by D2R antagonist 
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also alleviates huntingtin-induced death of striatal neurons (Charvin et al., 2005). 
Therefore, this study aimed to determine whether oxidative stress is involved in the 
reduced neurite outgrowth induced by D2R overactivation. 
1.2.16 Targeting Mitophagy as Novel Strategy for Treating Neurite Deficits 
Basal autophagy activity is critical to the maintenance of neuronal homeostasis and 
viability (Klionsky and Emr, 2000). Human cells have sophisticated regulatory 
pathways to maintain mitochondrial homeostasis through balanced mitochondrial 
biogenesis and clearance of damaged mitochondria. Mitophagy, a form of 
autophagy, mediates the removal of defective mitochondria (Lou et al., 2019). 
Neuronal autophagy also plays essential roles during neuronal development, for 
example, axon outgrowth and synapse formation (Tomoda et al., 2019). Mitophagy 
is crucial for protecting cells against the deleterious effects of damaged 
mitochondria (Yamada et al., 2019, Fang et al., 2019). In postmitotic neurons, the 
autophagosomes are continuously formed at the distal end of the axon and undergo 
transportation along microtubules toward the soma, which is enriched with 
lysosomes to clear unnecessary materials (e.g., amino acids, lipids) (Ashrafi et al., 
2014). A recent study further showed that macroautophagic activity within the 
learning and memory center is responsible for synaptic plasticity by maintaining 
the expression of NPY in drosophila (Bhukel et al., 2019).  
Disruptions in neuronal autophagy contribute to the pathophysiology of 
neuropsychiatric disorders (Tomoda et al., 2019). The SQSTM1 (also known as 
p62) is an autophagy substrate that is used as a reporter of autophagy activity (Liu 
et al., 2016). SQSTM1 is decreased when autophagy is induced while it is 
accumulated when autophagy is inhibited; therefore, SQSTM1 may be used as a 
biomarker to study the autophagic process (Bjørkøy et al., 2009). As elevated 
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SQSTM1 expression is found in the prefrontal cortex of schizophrenia patients, the 
autophagy-deficiency caused by hyperdopaminergic may be associate with 
SQSTM1 expression. One study reported that D2R knockdown inhibited 
autophagic influx, suggesting D2R is a positive regulator of autophagy (Wang et 
al., 2018). Recently, Aveleira and colleagues have shown that NPY can initiate 
autophagy in the hypothalamic neuronal cell line, as shown by the analysis of 
LC3B-II turnover, the decrease of SQSTM1 and the increase in the number of 
autophagosomes and autolysosomes (Aveleira et al., 2015). The research on D2R 
induced neuronal autophagy will also help us to have a greater level of 
understanding in the signaling pathway involving D2R-NPY-autophagy. 
Interestingly, quinpirole decreases cell viability without initiating neuronal 
autophagy (Leng et al., 2017). Thus, whether and how D2R activation regulates 
mitophagy is still largely unknown. A better understanding of D2R and mitophagy 




1.3 Aims and Hypothesis 
1.3.1 Specific Aims 
The aims of this research were to:  
1. Study whether and how the excessive D2R-DISC1 complex formation affects 
neurite outgrowth, D2R intracellular signaling, and synaptic proteins in the primary 
neurons. 
2. Evaluate the effects of haloperidol and aripiprazole on D2R-DISC1 complex 
formation and neuroprotection. 
3. Determine the neuroprotective effects of novel antipsychotic peptide TAT-
D2pep and mechanisms underlying its protection in primary the striatal neurons. 
4. Investigate the effects of D2R overactivation on oxidative stress and mitophagy 





1. The excessive D2R-DISC1 complex caused by D2R specific agonist quinpirole 
will decrease the phosphorylation of Akt-GSK3β, which will lead to the reduction 
of neurite growth and dendritic spine density. Furthermore, quinpirole will decrease 
the expression of synaptic proteins, indicating that the increased interaction 
between D2R and DISC1 will also cause synaptic loss. 
2. Aripiprazole may have better protection on neuronal morphology than 
haloperidol.  
3. TAT-D2pep will protect neurite outgrowth and dendritic spine formation by 
specifically decreasing D2R-DISC1 complex formation.  
4. Overactivation of intracellular and mitochondrial D2R will cause oxidative stress 





Schizophrenia influences approximately 20 million people throughout the world. 
Antipsychotic drugs are the primary medication for the treatment of schizophrenia 
as well as other psychiatric disorders. Nevertheless, the absence of response to 
antipsychotics in certain patients, along with their various side-effects, driving 
researchers to find a better treatment for schizophrenia. D2R antagonism is a 
general pharmacodynamic property of all current antipsychotics, which further 
supports that D2R hyperactivity is a core target for schizophrenia treatment. In 
addition, clinical and pre-clinical findings have indicated that neurite deficits are 
associated with schizophrenia featured by cognitive decline. Synaptic loss is 
considered as the critical phenotype of schizophrenia. Previous findings 
demonstrate that the reduction of dendritic spines in the brain is not the 
consequence of treatment with antipsychotic medications. Thus, investigating the 
effects of D2R overactivation on neuronal impairment, and antipsychotic drugs 
target which signaling pathway of D2R, will contribute to understanding the 
mechanisms of D2R overactivation induced neurite lesion from several interrelated 
perspectives. Comparing the effects of haloperidol and aripiprazole on 
neuroprotection will help us have a better understanding of the features of atypical 
and typical antipsychotic drugs.  
The dysfunction of D2R complexes in schizophrenia subjects is a promising target 
in neuropsychopharmacology. These D2R complexes could offer novel targets for 
antipsychotic drugs and provide better therapeutic outcomes. The excessive D2R-
DISC1 complex was recently identified in the post-mortem brain from 
schizophrenia patients and mouse models of schizophrenia. However, the role of 
the D2R-DISC1 complex in neuroplasticity is still unclear. The findings in this 
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thesis will provide evidence of whether the cell-penetrating peptide TAT-D2pep 
targeting on the D2R-DISC1 complex has neuroprotective effects. In addition, 
oxidative stress has been recently determined in the first episode of drug-naïve 
schizophrenia patients with cognitive deficits. Elucidating the effects of D2R 
overactivation caused oxidative stress on neurite outgrowth will provide another 
important mechanism underlying neurite deficits. Results from the current study 
may offer evidence for developing new antipsychotic drugs targeting on 




1.4 General Methods 
1.4.1 Antibodies and Chemicals 
The reagents used in this thesis are summarized in Table 1.4.1. 
 
Table 1.4.1 Summary of Materials in the Thesis 
 
Reagent Source Identifier 
Antibodies   
Mouse monoclonal anti-D2R Santa Cruz sc-5303 
Mouse monoclonal anti-GAD67 Millipore MAB5406 
Mouse monoclonal anti-CaMKII-α Cell Signaling 50049 
Mouse monoclonal anti-β-actin Millipore MAB1501 








Rabbit monoclonal anti-Akt Ser473 Cell Signaling 4060 
Rabbit monoclonal anti-Akt Thr308 
 
Cell Signaling 13038 
Rabbit monoclonal anti-Akt (pan) Cell Signaling 4685 
Rabbit monoclonal anti-GSK3α/β Cell Signaling 5676 
Rabbit monoclonal anti-GSK3β 
 
Cell Signaling 5558 
Rabbit monoclonal anti-NPY Sant Cruz sc-133080 
Rabbit monoclonal anti-DISC1 Abcam EPR14684 
Donkey anti-mouse Alexa Fluor 488 Invitrogen A21202 
Donkey anti-rabbit Alexa Fluor 568 Invitrogen A10042 
Goat anti-rabbit Alexa Fluor 488 Invitrogen A11008 
Goat anti-mouse Alexa Fluor 568 Invitrogen A11004 
Donkey anti-goat Alexa Fluor 647 Invitrogen A21447 
Donkey anti-rabbit Alexa Fluor 
 
Invitrogen A37573 
Donkey anti-mouse Alexa Fluor 
 
GE Healthcare 1301 
Chemicals and Peptides   
Quinpirole hydrochloride Sigma Q102 
Haloperidol MP Biomedical 11403062 
Aripiprazole Sigma SML0935 
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Continued   
TAT-D2pep* GeneScript N/A 
TAT-D2pep-NC GeneScript N/A 
Cell Light™ Actin-RFP, BacMam 
 
Invitrogen C10583 
Phalloidin Alexa Fluor 568  Invitrogen A12380 
Neurobasal® Medium Thermofisher 21103049 
B27 Supplement Thermofisher 17504044 






Trypsin inhibitor Sigma T9253 
Poly-D-Lysine Sigma P7280 
REDExtract-N-Amp™ Tissue PCR 
 
Sigma XNAT 
TAE Buffer (Tris-acetate-EDTA) 
 
Sigma B49 
Donkey serum Sigma D9663 
Recombinant DNA   
D2R-eGFP GeneScript N/A 
DISC1-mCherry GeneScript N/A 
D2R mutation-eGFP GeneScript N/A 
D2R-Flag Sino Biological HG12111 
Experimental Models:   
Primary cortical neurons C57BL/6J (ABR) N/A 
Primary cortical neurons DISC1 (JHU) 
 
N/A 
Primary striatal neurons C57BL/6J (ABR) N/A 
HEK-293 cells ATCC CRL1573 
 
Abbreviations: ABR: Australian BioResources; JHU: Johns Hopkins University. 
*The design of TAT-D2pep was based on the region from K211 to T225 
(KIYIVLRRRRKRVNT) of D2R, which was known to directly interact with 
DISC1 (Su et al., 2014, Lipina et al., 2018). The molecular weight and purity of 
TAT-D2pep were analyzed by high-performance liquid chromatography (HPLC) 
and mass spectrometry (MS) before it was applied in experiments. 
1.4.2 Cortical and Striatal Neuron Culture 
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All experimental procedures were approved by the Animal Ethics Committee, 
University of Wollongong, Australia, and complied with the Australian Code of 
Practice for the Care and Use of Animals for Scientific Purposes. Dissociated 
mouse cortical (Chapter 2) and striatal cultures (Chapter 3 and Chapter 4) were 
prepared as previously described from postnatal 0 to 3-day-old C57BL/6J, or 
DISC1-LI mice described previously (kindly provided by Prof. A. Sawa, Johns 
Hopkins University School of Medicine) (Shahani et al., 2015, Seshadri et al., 
2015). To generate DISC1-LI mice, the exon1-3 and Δ25bp on Exon 6 of DISC1 
are deleted. Heterozygous DISC1-LI male and wild-type C57BL/6J female mice 
were mated to obtain heterozygous DISC1-LI and wild type pups. Genotypes were 
carried out by tail snipping and polymerase chain reaction prior to tissue collection 
at PN0. Briefly, cortical or striatal cells were gently dissociated with a plastic 
pipette after digestion with 0.5% trypsin (GIBCO, Los Angeles, USA) at 37°C for 
30 min. Cells were cultured in Neurobasal medium (GIBCO) containing B27 
supplement (GIBCO), 1M glucose (only for culturing cortical neurons) and 20mM 
glutamine (Sigma Aldrich). After 24 hours of culture, Cultures were maintained at 
37°C in a humidified 5% CO2 incubator and used for experiments at seven days in 
vitro. The half volume of the culture medium was changed twice a week. The final 
concentration of quinpirole used in this study was optimized based on its effect on 
the neurite length of cortical or striatal neurons, and the data was acquired by a 
Lionheart FX Automated Microscope (BioTek Instruments, Winooski, Vermont, 
USA). 
1.4.3 HEK-293 Cell Culture and Transfection 
HEK-293 cells were grown in DMEM (Life Technologies, Carlsbad, USA) 
containing 10% fetal bovine serum and 1% penicillin-streptomycin (Thermo 
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Fisher, Waltham, USA) at 37°C in 5% CO2. On the day before transfection, the 
culture medium was changed to DMEM containing 10% fetal bovine serum without 
penicillin-streptomycin. The D2R-EGFP, D2R mutant-EGFP, and DISC1-mCherry 
coding sequences were synthesized by GenScript (GenScript, Hong Kong Ltd) and 
sub-cloned into the pcDNA3 vector. To obtain the D2R mutant-EGFP, the 
sequence coding the DISC1 binding site, KIYIVLRRRRKRVNT, was deleted from 
the full sequence of the D2R long isoform. The D2R-Flag plasmid is from Sino 
Biological Incorporation (Beijing, China). Transfection was performed using 
Lipofectamine 2000 (Life Technologies) according to the manufacturer’s 
instructions. After 24 hours of transfection, cells were treated with different drugs. 
1.4.4 Immunofluorescence 
Cells for immunofluorescence were plated on 13 mm coverslips coated with 0.1 
μg/ml poly-d-lysine (Sigma Aldrich) at a final concentration of 1.0 × 105 cells/well. 
Following treatment, cells were fixed in 4% freshly-made formaldehyde, 
permeabilized with 0.3% Triton X-100/phosphate buffered saline (PBS), and 
blocked with 5% normal donkey serum (Sigma Aldrich) in PBS. Cells were first 
immunostained with primary antibodies overnight and then with secondary 
antibodies for 2 hr. Cells were viewed using a 63× oil immersion objective on a 
DMI6500B confocal microscope or DMi8 fluorescence microscope (Leica, 
Mannheim, Germany). The neurite length and branches were measured by 
manually tracing the neurites using ImageJ software (Rasband, W.S., ImageJ, U. S. 





1.4.5 Fluorescence Resonance Energy Transfer (FRET) 
Confocal FRET analysis was performed as described previously (Hasbi et al., 
2009). In the cortical neurons, anti-D2R-Alexa Fluor 488 was used as a donor 
dipole, while anti-DISC1-Alexa Fluor 568 was used as an acceptor dipole. In HEK-
293 cells, D2R-GFP was used as a donor dipole, while DISC1-mCherry was used 
as an acceptor dipole. The donor was excited with an argon laser at 488 nm, while 
the acceptor was excited with a DPSS laser at 568 nm. Samples were analyzed 
using the Leica application wizard for FRET sensitized emission.  
1.4.6 Western Blot 
After treatment, cells were immediately collected in lysis buffer containing NP40 
(Sigma Aldrich), protease inhibitor cocktail (Sigma Aldrich), 1 mM 
phenylmethylsulfonyl fluoride (Sigma Aldrich) and 0.5 mM β-glycerophosphate 
(Sigma Aldrich). Total protein concentrations were determined by the DC-Assay 
(BioRad, Hercules, USA), and detected using a SpectraMax Plus384 absorbance 
microplate reader (Molecular Devices, Sunnyvale, USA). The sample protein was 
separated on SDS-PAGE gels and then transferred onto polyvinylidene fluoride 
(PVDF) membranes. Incubation with primary antibodies was performed overnight 
at 4 °C. The blots were then washed and incubated with secondary antibodies for 2 
hours at room temperature. For visualization, immunoreactivity was detected using 
enhanced chemiluminescence detection reagents. The blots were scanned with an 
Amersham Imager 600 RGB (GE Health, Chicago, USA), and densitometry 





1.4.7 Super-resolution Imaging of D2R and DISC1 in Dendritic Spines 
Primary striatal neurons for STORM imaging were plated on µ-slide 8 well glass 
bottom plates (Ibidi, Martinsried, Germany). Endogenous D2R and DISC1 were 
fixed, cells were permeabilized and immunolabelled by primary and secondary 
antibodies conjugated with Cy3B-NHS and Alexa 647-NHS, respectively, as 
previously described (Du et al., 2016). An imaging buffer (100 mM Tris/HCl pH 
8.0, 20 mM NaCl and 10% glucose, all from Sigma-Aldrich) and an oxygen 
scavenger system (60 mg/ml glucose oxidase and 6 mg/ml catalase, both from 
Sigma-Aldrich) were used for STORM imaging (Wang et al., 2015) and 140 mM 
β-mercaptoethanol was added to promote photo-switching. Two-color STORM 
imaging was sequentially acquired for up to 50,000 frames under the excitation of 
647 nm and 561 nm lasers at a power density of 3~5 kW/cm2 and under the photo-
activation of a 405 nm laser (Coherent Inc.) with a power density of 0.5 kW/cm2 
at the sample. STORM image analysis, nearest neighbor distances calculation, drift 
correction, image rendering, protein nanocluster identification, quantification and 
image presentation were performed using Insight3 (a gift from Prof. Bo Huang at 
UCSF), custom-written Matlab (2012a, MathWorks) codes, SR-Tesseler (IINS, 
Interdisciplinary Institute for Neuroscience), and Image J (Image Processing and 
Analysis in Java). 
1.4.8 Cell preparation for cryo-EM 
Carbon-coated gold TEM grids (Quantifoil NH2A R2/2) were performed plasma 
cleaning at 2 mA for 10 seconds. Grids were sterilized under UV three times for 
30 min at room temperature. Grids were carefully washed twice in PBS and coated 
with 0.1 μg/ml poly-d-lysine for 1 hour at 37 °C. After three PBS washes, striatal 
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neurons were plated on a final concentration of 3.0 x 105 cells/grid. For cell 
vitrification, live striatal neurons were blotted from the backside of the grid for 9 s 
and rapidly frozen in liquid nitrogen using a Leica EMGP system. 
1.4.9 Image acquisition by Cryo-electron microscopy  
Cryo-ET was performed on a Tecnai 20 equipped with a field emission gun and 
operated at 200 kV (Thermo Fisher company). Images were captured using either 
Explore 3D or SerialEM software on a 4k x 4k camera (Ultrascan from Gatan) and 
a Falcon II (FEI, Thermo Fisher) direct electron detector, with a 14 μm pixel size. 
Tilt series of mitochondria were acquired covering an angular range of - 60° to + 
60° with a 2 to 4 degrees increment. All tilt series were acquired at magnifications 
of 25,000× or 29,000 ×, binning 2. Tomograms were manually segmented with the 
program AMIRA (FEI). 
1.4.10 Statistical analysis 
GraphPad Prism 7 (GraphPad Software, Inc., La Jolla, CA, USA) was used to 
calculate the significance between groups. Shapiro-Wilk test was used to examine 
if the data were normal distribution. Levene’s test of equality of error variances was 
performed to check the data for homogeneity of variance. The t-test was used to 
analyze the significant difference between the two groups. One-way ANOVA was 
performed for comparing the mean values of multiple groups, followed by Tukey’s 





1.5 Overview of the Thesis 
Schizophrenia is a severe mental disorder featured with impaired neuronal 
connections in the brain. All the current antipsychotic drugs target on D2R to 
counterbalance its hyperactivity associated with psychotic symptoms. However, the 
neurite deficits in the majority of schizophrenia are not ameliorated by current 
antipsychotic drugs. Thus, it is of great importance to understand the mechanism 
of D2R overactivation caused neurite deficits, which will provide evidence in 
developing the novel antipsychotic drugs. The phenotypes of the primary cortical 
and striatal neurons have been demonstrated to be relevant to the cortex and 
striatum in vivo. This study applied the primary neurons to investigate the 
mechanism of neurite impairment and evaluate the effects of antipsychotic drugs. 
Furthermore, the super-resolution technique facilitates us to observe the pattern of 
existence of interested proteins and the interaction of proteins within a single 
dendritic spine of neurons. This study highlights the significance of the D2R-
DISC1 complex as well as oxidative stress in neuroplasticity. These findings 
contribute to developing novel antipsychotic drugs to treat neurite deficits and 




1.5.1 Aripiprazole and haloperidol protect neurite lesions via reducing 
excessive D2R-DISC1 complex formation 
D2R hyperactivity causes altered brain development and later produces onset of 
symptoms mimicking schizophrenia. It is known that D2R interacts with DISC1; 
however, the effect of D2R-DISC1 interaction in intracellular signaling and neurite 
growth has not been studied. This study investigated the effect of D2R over-
activation on Akt-GSK3β signaling and neurite morphology in cortical neurons. 
Over-activation of D2Rs caused neurite lesions, which were associated with 
decreased Akt and GSK3β phosphorylation in cortical neurons. The antipsychotic 
drug aripiprazole was more effective in the prevention of neurite lesions than 
haloperidol. Unlike haloperidol, aripiprazole prevented downregulation of pAkt-
pGSK3β induced by D2R hyperactivity, indicating the involvement of different 
pathways. D2Rs were hyperactive in cortical neurons of mice with DISC1 
mutation, which caused more severe neurite lesions in cortical neurons treated with 
quinpirole. Immunofluorescent staining for CaMKII confirmed that cortical 
pyramidal neurons were involved in the D2R hyperactivity-induced neurite lesions. 
Using the FRET technique, we provide direct evidence that D2R hyperactivity led 
to D2R-DISC1 complex formation, which altered pGSK3β signaling. This study 
showed that D2R hyperactivity-induced D2R-DISC1 complex formation is 
associated with decreased pAkt-pGSK3β signaling and, in turn, caused neurite 
impairment. Aripiprazole and haloperidol prevented the impairment of neurite 




1.5.2 Prevention of Neurite Spine Loss Induced by Dopamine D2 Receptor 
Overactivation in Striatal Neurons 
Psychosis has been considered a disorder of impaired neuronal connectivity. 
Evidence for excessive formation of D2R-DISC1 complexes has led to a new 
perspective on molecular mechanisms involved in psychotic symptoms. Here, we 
investigated how excessive D2R-DISC1 complex formation induced by D2R 
agonist quinpirole affects neurite growth and dendritic spines in striatal neurons. 
Fluorescence resonance energy transfer, stochastic optical reconstruction 
microscopy, and cell penetrating-peptide delivery were used to study the cultured 
striatal neurons from mouse pups. Using these striatal neurons, our study showed 
that: (1) D2R interacted with DISC1 in dendritic spines, neurites and soma of 
cultured striatal neurons; (2) D2R and DISC1 complex accumulated in clusters in 
dendritic spines of striatal neurons and the number of the complex were reduced 
after application of TAT-D2pep; (3) uncoupling D2R–DISC1 complexes by TAT-
D2pep protected neuronal morphology and dendritic spines; and (4) TAT-D2pep 
prevented neurite and dendritic spine loss, which was associated with restoration 
of expression levels of synaptophysin and PSD-95. In addition, we found that NPY 
and GSK3β were involved in the protective effects of TAT-D2pep on the neurite 
spines of striatal spiny projection neurons. Thus, our results may offer a new 





1.5.3 Overactivation of Mitochondrial Dopamine D2 Receptor Inhibits 
Mitophagy 
Oxidative stress has been recently observed in the first episode of drug-naïve 
schizophrenia patients. Although D2R dysfunction has long been recognized in 
schizophrenia pathology, whether it can affect mitochondrial ultrastructure and 
ROS-mediated mitophagy are largely unidentified. Here, we investigated how D2R 
over-activation inhibits ROS-initiated mitophagy and working memory in mice. 
Cryogenic electron microscopy (Cryo-EM) and schizophrenia mice model were 
used in this study. Our findings showed that (1) D2R overactivation caused by 
quinpirole reduced number and length of cristae in mitochondria of cultured striatal 
neurons; (2) D2R located on neuronal mitochondria; (3) D2R specific agonist 
quinpirole exacerbated oxidative stress with increased ROS and malondialdehyde 
(MDA) in primary striatal neurons; (4) SQSTM1 expression was up-regulated by 
quinpirole suggesting the mitophagy was inhibited; (5) Administration of 
quinpirole caused working memory impairment and stereotyped behavior in adult 
mice. Therefore, these findings may provide a new strategy for alleviating oxidative 




In summary, D2R overactivation caused neurite lesion is associated with excessive 
D2R-DISC1 complex formation and incomplete mitophagy. This study for the first 
time discovers that the unbalanced interaction between D2R and DISC1 result in 
reductions in neurite outgrowth and dendritic spine formation. This study also 
examined the alternation of the D2R intracellular signaling pathway, which is 
associated with the neuroplasticity. The excessive formation of the D2R-DISC1 
complex decreased the phosphorylation of GSK-3β in cortical and striatal neurons. 
D2R overactivation also downregulated the NPY expression level, while disrupting 
D2R-DISC1 complex caused by D2R overactivation restored the NPY level to 
normal. Besides the impairment in neuronal morphology, this study also reported 
the inhibited synaptic connections caused by increased interaction of D2R and 
DISC1. 
By comparing the effects of haloperidol and aripiprazole on neuroplasticity, the 
findings showed that aripiprazole had better protection on neurite length than 
haloperidol. Aripiprazole could increase the expression level of phosphorylated 
GSK3β, whereas haloperidol had no effects on GSK3β phosphorylation. Using 
DISC1 mutant mice, this study also demonstrated that haloperidol and aripiprazole 
prevented neurite impairment through DISC1. In addition, this study first identified 
that both haloperidol and aripiprazole could block the quinpirole-induced 
interaction of D2R and DISC1 in cultured cortical and striatal neurons. This thesis 
has also firstly reported that TAT-D2pep disrupted the interaction between D2R 
and DISC1 to prevent neurite lesions, suggesting this complex would be a potential 
therapeutic approach for treating neurite deficits.  
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Protein-protein interactions exist in the synapse to affect synaptic architecture and 
neurotransmission. Here, STORM images revealed that both D2R and DISC1 
existed within synapse in a nanocluster pattern instead of a single molecular. The 
cell-penetrating peptide TAT-D2pep separated the complex of D2R and DISC1 in 
synapses, suggesting that this peptide with antipsychotic-like effects may be 
capable of strengthening synaptic plasticity. Interestingly, the diameter of D2R and 
DISC1 nanoclusters was not changed by quinpirole or TAT-D2pep. This study for 
the first time reports the relationship between the actual distance of proteins and 
FRET occurrence, which is the first time that FRET has been elucidated from a 
nanoscale perspective. 
Finally, this study reported that oxidative stress and incomplete mitophagy were 
involved in the neurite lesion caused by D2R overactivation. Cryo-EM has been 
the dominant technique to observe fine structures, like mitochondrion, inside the 
neuronal synapse. The current study observed that D2R overactivation damaged 
mitochondrial cristae, suggesting that the importance of D2R in controlling 
mitochondrial integrity. Furthermore, this study for the first time reveals the 
existence of D2R on the mitochondrial membrane. Overactivation of mitochondrial 
D2R remarkably stimulates mitochondrial ROS production. Understanding D2R 
subcellular localization can actively contribute to receptor function and even 
disease pathology. This study also demonstrated that mitophagy inhibition might 
be another mechanism underlying membrane and mitochondrial D2R 
overactivation.  
Taken together, these findings have provided extensive new knowledge on the 
mechanism of D2R in regulating neuroplasticity. The TAT-D2pep could be a new 
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Fig. S2 Genetic background of DISC1-LI mice. To generate DISC1-LI mice, 
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Overactivation of Dopamine D2 Receptor Inhibits Mitophagy 
Abstract 
Oxidative stress has been recently observed in the first episode of drug-naïve 
schizophrenia patients. Although D2R dysfunction has long been recognized in 
schizophrenia pathology, whether it can affect mitochondrial ultrastructure and 
reactive oxygen species (ROS)-mediated mitophagy are unknown. Here, this study 
determined if D2R overactivation by quinpirole affects mitochondrial ultrastructure 
in cultured primary striatal neurons by cryo-electron tomography (Cryo-ET). The 
oxidative stress, mitophagy, and neurite outgrowth were further examined in 
quinpirole-treated neurons. The present study showed that (1) quinpirole decreased 
number and length of cristae in mitochondria of cultured striatal neurons; (2) D2R 
located on neuronal mitochondria; (3) D2R specific agonist quinpirole exacerbated 
oxidative stress with increased ROS and malondialdehyde (MDA) in primary 
striatal neurons; and (4) SQSTM1 expression was up-regulated by quinpirole 
suggesting the mitophagy process was inhibited. Altogether, this study indicates 
that D2R overactivation inhibits oxidative stress-induced mitophagy deficit, which 
may be involved in neurite impairment. The identification of mitochondrial D2R 





Schizophrenia is a complex mental disorder influenced by genetic and 
environmental factors; however, the underlying pathological mechanisms are 
mostly unknown (Howes et al., 2016). Oxidative stress has recently been identified 
in the first episode of drug-naïve patients with schizophrenia and cognitive deficits 
(Solberg et al., 2019, Xie et al., 2019). Another study also observed increased lipid 
peroxidation, particularly in first-episode drug naïve patients with schizophrenia. 
These findings suggest that oxidative stress is involved in the pathogenesis and 
progression of schizophrenia (Jordan et al., 2018).  
D2R dysfunction has long been reported in schizophrenia and psychiatric disorders 
(Kostrzewa et al., 2018). Striatal D2R upregulation is frequently documented in 
schizophrenia patients without antipsychotic treatment history (Kubota et al., 2017). 
Recent pharmacological studies involving antipsychotics highlighted how D2R 
signaling could regulate mitochondrial ROS production (Anglin et al., 2012). A 
growing list of mitochondrial G-protein coupled receptors (GPCR) have also been 
linked with mitochondrial ROS production and include the 5-HT4 receptor (Wang 
et al., 2016), cannabinoid CB1 receptors (Benard et al., 2012), and melatonin MT1 
receptors (Ahluwalia et al., 2018). The existence of D2R in neuronal mitochondria 
has not yet been confirmed, although past studies showed that administration of the 
D2R agonists, quinpirole and dopamine, could directly affect mitochondrial 
functions (Brenner-Lavie et al., 2008). Besides the well-known functions of D2R 
in the cell membrane, it is hypothesized here that D2R is located on the 
mitochondria and regulates mitochondrial ROS production.  
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The selective removal of damaged mitochondria by autophagy (mitophagy) is the 
primary approach to degrade damaged or unwanted mitochondria (Lou et al., 2019). 
Mitophagy is crucial for protecting cells against the deleterious effects of damaged 
mitochondria (Yamada et al., 2019, Fang et al., 2019). Nevertheless, how D2R 
overactivation regulates mitophagy is still unclear. Subsequently, a better 
understanding of D2R and mitophagy might provide new therapeutic targets for the 
treatment of schizophrenia. 
The present study firstly showed that D2R overactivation caused mitochondrial 
ultrastructure damage. This observation prompted investigations into the existence 
of D2R in neuronal mitochondria. Furthermore, over activating D2R led to 
oxidative stress, incomplete mitophagy, and neurite impairment in cultured striatal 
neurons.  
4.2 Materials and Methods 
4.2.1 Antibodies and chemicals 
The following reagents were purchased: Quinpirole hydrochloride (Sigma Aldrich, 
St Louis, Missouri, USA), anti-MAP2 (1:1,000; Sigma Aldrich), anti-β-actin 
(1:5000; Millipore, Bedford, USA), anti-D2R (1:400, Santa Cruz Biotechnology, 
CA, USA), and Alexa Fluor 568-conjugated goat anti-rabbit IgG secondary 
antibody (1:400; Invitrogen). D2R shRNA was synthesized by GenScript 
(GenScript, Hong Kong Ltd). 
4.2.2 Striatal neuron culture 
The experimental procedures were approved by the Animal Ethics Committee, the 
University of Wollongong, Australia (AE18/07), and comply with the Australian 
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Code of Practice for the Care and Use of Animals for Scientific Purposes. Striatal 
cells were gently dissociated with a plastic pipette after digestion with 0.5% trypsin 
(GIBCO, Los Angeles, USA) at 37°C for 30 min. Cells were cultured in Neurobasal 
medium (GIBCO) containing B27 supplement (GIBCO) and 20 mM glutamine 
(Sigma Aldrich). Cultures were maintained at 37°C in a humidified 5% CO2 
incubator.  
4.2.3 Cell preparation for cryo-EM 
Plasma cleaning of carbon-coated gold TEM grids (Quantifoil NH2A R2/2) was 
performed at 2 mA for 10 seconds. Grids were sterilized under UV for 30 min at 
room temperature. Grids were carefully washed twice in PBS and coated with 0.1 
μg/ml poly-d-lysine for 1 hour at 37 °C. After three PBS washes, striatal neurons 
were plated on a final concentration of 3.0 x 105 cells/grid. For cell vitrification, 
live striatal neurons were blotted from the backside of the grid for 9 s and rapidly 
frozen in liquid nitrogen using a Leica EMGP system. 
4.2.4 Image acquisition by Cryo-electron microscopy  
Cryo-ET was performed on a Tecnai 20 equipped with a field emission gun and 
operated at 200 kV (Thermo Fisher company). Images were captured using either 
Explore 3D or SerialEM software on a 4k x 4k camera (Ultrascan from Gatan) and 
a Falcon II (FEI, Thermo Fisher) direct electron detector, with a 14 μm pixel size. 
Tilt series of mitochondria were acquired covering an angular range of - 60° to + 
60° with a 2 to 4 degrees increment. All tilt series were acquired at magnifications 
of 25,000× or 29,000 ×, binning 2. Tomograms were manually segmented with the 
program AMIRA (FEI). 
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4.2.5 HEK-293 cell culture and transfection 
HEK-293 cells had no expression of D2R (Thul et al., 2017). In order to study the 
effect of over-activation by quinpirole on mitochondria, D2R plasmid was 
transfected into HEK-293 cells. HEK-293 cells were grown in Dulbecco's modified 
Eagle's medium (DMEM; Life Technologies, Carlsbad, USA) containing 10% fetal 
bovine serum and 1% penicillin-streptomycin (Thermo Fisher) at 37°C in 5% CO2. 
On the day before transfection, the culture medium was changed to DMEM 
containing 10% fetal bovine serum without penicillin-streptomycin. The D2R-
EGFP coding sequences were synthesized by GenScript (GenScript, Hong Kong 
Ltd) and sub-cloned into the pcDNA3 vector. Transfection was performed using 
Lipofectamine 2000 (Life Technologies) according to the manufacturer's 
instructions. 
4.2.6 Immunofluorescence 
Cells for immunofluorescence were plated on 13 mm coverslips coated with 0.1 
μg/ml poly-d-lysine (Sigma Aldrich) at a final concentration of 1.0 × 105 cells/well. 
Following treatment, cells were fixed in 4% freshly made formaldehyde, 
permeabilized with 0.3% Triton X-100/phosphate-buffered saline (PBS), and 
blocked with 5% normal donkey serum (Sigma Aldrich) in PBS. Cells were firstly 
immunostained with primary antibodies overnight and then with secondary 
antibodies for 2 hours. Cells were viewed using a 63× oil immersion objective on 
a TCS SP8 confocal microscope (Leica, Mannheim, Germany).  
4.2.7 Western blot 
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After treatment, cells were immediately collected in lysis buffer containing NP40 
(Sigma Aldrich), protease inhibitor cocktail (Sigma Aldrich), one mM 
phenylmethylsulfonyl fluoride (Sigma Aldrich) and 0.5 mM β-glycerophosphate 
(Sigma Aldrich). Total protein concentrations were determined by the DC-Assay 
(BioRad, Hercules, USA) and detected using a SpectraMax Plus384 absorbance 
microplate reader (Molecular Devices, Sunnyvale, USA). The sample protein was 
separated on SDS-PAGE gels and then transferred onto polyvinylidene fluoride 
(PVDF) membranes. Incubation with primary antibodies was performed overnight 
at 4 °C. The blots were then washed and incubated with secondary antibodies for 2 
hours at room temperature. For visualization, immunoreactivity was detected using 
enhanced chemiluminescence detection reagents. The blots were scanned with an 
Amersham Imager 600 RGB (GE Health, Chicago, USA), and densitometry 
analysis was performed with ImageQuant TL 8.1 Software (GE Health, Chicago, 
USA). 
4.2.8 Statistical analysis 
GraphPad Prism 7 (GraphPad Software, Inc., La Jolla, CA, USA) was used to 
calculate the significance between groups. For significance analyses of multi-
groups, p-values were determined by one-way analysis of variance (ANOVA) 
followed by Tukey's post hoc corrections. Data were expressed as means ± SEM, 
and p < 0.05 was considered statistically different. 
4.3 Results 
4.3.1 Cryo-ET reveals the abnormal architecture of mitochondrial cristae in 
striatal neurons induced by D2R agonist  
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The Cryo-ET is an advanced technique to observe the ultrastructure of 
mitochondria within its native environment (Tao et al., 2018). To investigate the 
effect of D2R overactivation on mitochondrial ultrastructure, this study applied 
cryo-ET to analyze the alterations of mitochondria treated with or without D2R 
specific agonist quinpirole. Primary striatal neurons were cultured on carbon-
coated gold grids and vitrified before loading to Cryo-EM. Each tilt series were 
reconstructed into a three-dimensional tomogram representing an intact 
mitochondrion within its native environment (Figure 1A). In the control group, the 
mitochondria showed normal morphology with the intact mitochondrial inner and 
outer membrane, as well as canonical cristae folding. However, the mitochondria 
of the quinpirole group exhibited remarkable ultrastructural defects compared with 
the control group, including a decreased number of folded cristae and length of 
cristae (Figure 1B and C). These results suggest that overactivation of D2R could 











Figure 4.1 Cryo-ET of mice striatal mitochondria from neurons treated with 
or without quinpirole. (A) Tomographic slice from a reconstructed stack of 
images taken at different tilt angles of one striatal mitochondrion. The tilt degree is 
± 70. Scale bar = 200 nm. (B) Corresponding three-dimensional segmentation of 
the mitochondrion from the control and quinpirole group. Quinpirole damaged 
striatal mitochondrial ultrastructure with fewer cristae. Scale bar = 20 nm. (C) The 





4.3.2 Identification of D2R on neuronal mitochondria 
Since this study found that D2R agonist quinpirole impaired the mitochondria 
ultrastructure of neurons, I investigated if D2R existed on the neuronal 
mitochondria. The primary striatal neurons were co-stained with D2R-Alexa 568 
antibody and mitochondrial marker MitoTracker Green. The fluorescent images 
showed that the co-localization of D2R and mitochondria distributed not only in 
soma but also on the neurite (Figure 2A). The co-localization of D2R with 
mitochondria was quantified by measuring the overlapped fluorescence intensities 
along neurite. The overlapped signal peaks in fluorescent intensities of D2R and 
mitotracker revealed that D2R was co-localized with mitochondria on the neurite 
of primary striatal neurons (Figure 2B). To further confirm D2R expresses on 
neuronal mitochondria, primary striatal neurons were incubated with D2R shRNA 
followed by immunoblot analysis. D2R shRNA transfected into cultured neurons 
significantly down-regulated D2R protein level of striatal neurons. (Figure 2C and 
D). The expression of D2R was detected in the isolated mitochondria from cultured 
striatal neurons. Moreover, D2R shRNA significantly decreased the D2R 
expression level in isolated mitochondria (Figure 2E). Taken together, these data 






























Figure 4.2 D2R exists in neuronal mitochondria. (A-B) Fluorescent detection of 
D2Rs on mitochondria of primary striatal neurons in the wild-type mice. (B) Co-
localization analysis of D2R with mitochondria in cultured striatal neurons. The 
graph shows the overlap of fluorescence intensity peaks of D2R and mitochondria 
along neurite, as indicated in the merged micrograph. Scale bar = 5 µm. Arrows, 
specific co-localization of D2R with mitochondria. (C) Representative images of 
D2R expression in striatal cell lysate (SCL) and purified mitochondria treated with 
or without D2R shRNA. (D-E) Quantification of D2R expression in cultured striatal 
cell lysates and isolated mitochondria. N=3, experiments were performed in 
triplicate. Data were shown as means ± SEM. * p < 0.05. 
4.3.3 D2R overactivation elevates ROS and oxidative stress in striatal neurons  
It is reported that the impairment of mitochondrial ultrastructure can lead to the 
accumulation of ROS (Jezek et al., 2018). To determine whether quinpirole 
increases intracellular ROS level, the primary striatal neurons were firstly treated 
with different concentrations of quinpirole followed by staining with DCFDA, an 
intracellular ROS marker. Quinpirole increased intracellular ROS level in U shaped 
dose-response curves (Figure 3A). Quinpirole at 20, 40, and 60µM increased ROS 
with the maximum effects at 20µM, while quinpirole at 10 and 100 µM did not 
significantly affect intracellular ROS production (Figure 3B). I further confirmed 
that quinpirole at 20 µM increased ROS production in striatal neurons by 
visualizing the increased intensity of DCFDA (Figure 3C). The flow cytometric 
analysis revealed that the increment of mitochondrial ROS was significant at 20 
µM quinpirole, which was similar to the alternation of intracellular ROS (Figure 
3D and E). The immunofluorescent images also displayed that quinpirole at 20 µM 
increased the intensity of MitoSox Red in the cultured striatal neurons (Figure 3F). 
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To investigate the role of mitochondrial D2R in ROS increment, isolated 
mitochondria from D2R transfected HEK-293 cells were incubated with 20 µM 
quinpirole. Quinpirole treatment displayed the higher fluorescent intensity of 
MitoSox compared with the control mitochondria (Figure 3G). MDA, an indicator 
of oxidative stress, is produced from the degradation of the cell membrane by 
excessive ROS (Massaad and Klann, 2011). This study further found that 
quinpirole significantly increased the MDA level (Figure 3H). Thus, these findings 
demonstrate that D2R overactivation induced ROS production and oxidative stress 































Figure 4.3 Quinpirole increases reactive oxygen species (ROS) generation in 
cultured striatal neurons. (A) The effects of quinpirole on intracellular ROS of 
primary striatal neurons. The striatal neurons were treated with quinpirole at 
different concentrations, including 0, 10, 20, 40, 60, and 100 μM. Intracellular ROS 
was assessed using the DCFDA probe after treatment with quinpirole for 24 h and 
quantified by flow cytometry. (B) Flow cytometry of intracellular ROS marked by 
DCFDA after primary striatal neurons treated with 20 μM quinpirole. (C) 
Representative fluorescent images of intracellular ROS in cultured striatal neurons 
treated with 20 μM quinpirole (D) The effects of quinpirole on mitochondrial ROS. 
MitoTracker 







The neurons were incubated for 24 h with different quinpirole concentrations. 
Mitochondrial ROS generation was detected using the MitoSox Red and quantified 
by flow cytometry. (E) Flow cytometry of mitochondrial ROS after cultured striatal 
neurons treated with 20 μM quinpirole. (F) Representative fluorescent images of 
mitochondrial ROS marked by MitoSox in primary striatal neurons treated with 20 
μM quinpirole. (G) Quinpirole increases ROS production in isolated mitochondria 
from HEK-293 transfected with D2R plasmid. (H) Overactivation of D2R by 
quinpirole at 20 μM increases the MDA level in primary striatal neurons. N=3, 
experiments were performed in triplicate. Data were shown as means ± SEM. *** 
p < 0.001, ** p < 0.01 or * p < 0.05 compared with the controls. Each column 
represents the means ± SEM. 
4.4.4 D2R overactivation increases autophagosome, but not autolysosomes 
Excessive mitochondrial ROS contributes to initiating mitophagy, which eliminates 
damaged mitochondria (Schofield and Schafer, 2020). Since I found that quinpirole 
treatment increased ROS production, I examined if quinpirole initiates the 
autophagy process to clear impaired mitochondria in striatal neurons. During the 
process of autophagy, an increase in the conversion rate of LC3-I to LC3-II 
indicates enhanced autophagosome formation (Liu et al., 2016). In the quinpirole-
treated neurons, not only the LC3-II protein level, but also LC3-II/LC3-I ratio was 
significantly increased compared with control group (Figure 4A and B), suggesting 
that D2R overactivation led to autophagosome formation. Furthermore, the co-
localization of LC3-II with mitochondria marker, Mitotracker Green, was 
significantly increased in quinpirole-treated striatal neurons (Figure 4C and D), 
confirming abnormal mitochondria are started for autophagic degradation. The 
SQSTM1 is degraded with autolysosome formation, indicating autophagy 
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completion (Larsen et al., 2010). However, the present study found that SQSTM1 
protein expression and immunofluorescent level significantly increased in 
quinpirole-treated primary striatal neurons (Figure 4E-G), suggesting inhibition of 
autolysosome formation by D2R over-activation. Overall, these results indicated 
that D2R overactivation failed to remove damaged mitochondria by mitophagy. 
Quinpirole could initiate the formation of autophagosome, but not process to 































Figure 4.4 Overactivation of D2R inhibits mitophagy. (A-B) Immunoblot 
analysis of LC3-I and LC3-II expression after quinpirole treatment. (C-D) 
Representative images and quantification of the co-localization of LC3-II with 
mitochondria. Cultured striatal neurons after quinpirole treatment were co-stained 
with LC3 II and Mitotracker Green. (E-F) Immunoblot analysis of SQSTM1 
expression after quinpirole treatment. (G) Representative immunofluorescent 
images of the up-regulation of SQSTM1 in primary striatal neurons. N=3, 
experiments were performed in triplicate. Data were shown as means ± SEM. ** p 
< 0.01 or * p < 0.05 compared with the controls. 
 
  





4.5 D2R overactivation impairs neurite in cultured striatal neurons 
It has been reported that dysfunctional mitophagy inhibits neurite growth 
(Chakravorty et al., 2019). Since the above study showed that the mitophagy 
process was inhibited by D2R overactivation, a further experiment was designed to 
determine whether this incomplete mitophagy affects neurite growth. The cultured 
striatal neurons were incubated with 20 µM quinpirole for 24 hours, which was 
demonstrated to inhibit mitophagy (Figure 4). The result showed that quinpirole 
treatment significantly shortened the average length of neurite compared with the 
control group (Figure 5 A and B). Moreover, the number of branches was also 
significantly decreased in primary striatal neurons treated with quinpirole (Figure 
5C). These findings suggest that incomplete mitophagy induced by D2R 







Figure 4.5 D2R overactivation suppresses neurite outgrowth in the primary 
striatal neurons. (A) Representative immunofluorescent images for cultured 
striatal neurons treated with or without quinpirole at 20 μM for 24 hours. Scale 
bar=100 μm. (B) Quantification of neurite length of striatal neurons treated with or 
without quinpirole. (C) Quantification of neurite branches of striatal neurons 
treated with or without quinpirole. N=3, experiments were performed in triplicate. 












Over-stimulation of D2R damages the ultrastructure of neuronal mitochondria with 
fewer cristae observed in Cryo-ET. D2R specific agonist quinpirole causes 
elevation of ROS production and MDA level in cultured striatal neurons. Notably, 
SQSTM1 is unable to be degraded after quinpirole treatment, indicating the 
mitophagy cannot be completed due to D2R overactivation.  
In the current study, our cryo-ET analysis firstly provided strong evidence that 
overactivation of D2R damages mitochondrial ultrastructure in primary striatal 
neurons. Conventional EM observations have shaped much of our current 
knowledge about mitochondrial alterations in schizophrenia (Sorra and Harris, 
2000; Harris and Weinberg, 2012). For example, a reduced density of mitochondria 
is reported in the striatum and prefrontal cortex of post-mortem brains in 
schizophrenia subjects (Uranova et al., 2001). However, ultrastructural studies of 
mitochondria are only possible with well-preserved brain tissue within short post-
mortem intervals. Furthermore, the sample preparation of conventional EM 
requires the chemical fixation and embedding process, which are highly possible to 
cause damage and shrinkage of mitochondrial structures (Siegmund et al., 2018). 
In this study, the live striatal neurons were applied plunge-freezing within seconds, 
which significantly improves structural preservation. Frozen striatal neurons on the 
grid were directly observed in the Cryo-EM chamber without sectioning. This study 
was the first to report that mitochondrial cristae were damaged after D2R was over-
stimulated in striatal neurons, indicating the critical role of D2R in controlling 
mitochondrial integrity. A similar result was also reported that more than 90% of 
mitochondria show damaged cristae in dopamine treated human neuroblastoma 
cells (Zilocchi et al., 2018). Although D2R was linked to mitochondria function 
108 
 
before, its role in mitochondrial ultrastructure has not been revealed so far. Further 
experiments may need to study the effects of D2R activation on mitochondrial 
function, such as ATP synthesis.   
This study is the first to demonstrate that D2R was located on the neuronal 
mitochondria. Accumulating evidence demonstrates that mitochondria are essential 
targets for the actions of dopamine (Burbulla et al., 2017, Chen et al., 2008, Devine 
and Kittler, 2018), suggesting that the potential existence of D2R on mitochondria. 
This study reported that the existence of D2R immunoblotting signal in isolated 
mitochondria of striatal neurons. Importantly, images revealed that D2R is co-
localized with mitochondria on the neurite of striatal neurons, suggesting 
mitochondrial D2R may have a role in regulating neurite growth. One study showed 
that D2R is located around the mitochondrial membrane by transmission electrical 
microscopy, although the author did not mention the existence of mitochondrial 
D2R (Lane et al., 2012). Taken together, understanding D2R subcellular 
localization can actively contribute to receptor function and even disease pathology. 
As the new roles of mitochondrial D2R need to be defined, the development of 
antipsychotics to both mitochondrial and membrane D2R would produce better 
therapeutic outcomes for patients.  
The current study provided evidence that the overactivation of D2R by quinpirole 
increases cellular ROS production in primary striatal neurons. Although many 
studies have already revealed that dopamine causes oxidative stress through 
dopamine receptors, the role of D2R in ROS production is not fully explained. A 
previous study demonstrated that dopamine shows no effect on ROS production 
and huntingtin protein aggregation in striatal neurons cultured from D2R knockout 
mice, suggesting that D2R mediates oxidative stress and neurotoxicity (Charvin et 
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al., 2005). The mitochondrion is a significant site for ROS production. The 
uncontrolled ROS accumulation can further damage mitochondria (Itoh et al., 
2013). The findings confirmed that overactivation of D2R by its specific agonist 
increases mitochondrial ROS production in neurons and isolated mitochondria. 
Further, this study demonstrated that the excess of mitochondrial ROS induced by 
D2R overactivation evoked membrane lipoxidation, indicated by increased MDA. 
To my knowledge, this study was the first to reveal the role of D2R in regulating 
oxidative stress in striatal neurons. Interestingly, neuronal cultures exposed to 
dopamine show oxidative stress as well as a significant decrease in dendritic spines 
(Beckhauser et al., 2016). Overactivation of D2R by quinpirole impairs neurite and 
synaptic spines in cortical and striatal neurons (Zheng et al., 2018). Consistent with 
previous findings, the current study showed that quinpirole at 20 µM decreased 
neurite length and branches. The current study implies that excessive ROS 
generation may underly the mechanism of neuronal impairment caused by D2R. 
Further experiments are required to explore the effects of D2R on the antioxidant 
system in the brain. 
Mitophagy belonging to a type of autophagy, which aims to eliminate damaged 
mitochondria in schizophrenia (Tomoda et al., 2019). Although several published 
findings reported that mitophagy is inhibited by antagonizing or down-regulating 
D2R, whether over activating D2R will inhibit the mitophagy process is not well 
understood (Klein et al., 2019). In the present study, quinpirole un-regulated LC3-
II expression, suggesting that promoted autophagosome formation at the initial 
stage of mitophagy. The increased expression of SQSTM1 suggests that autophagic 
clearance or transportation is impaired (Su et al., 2018). In this study, although 
autophagosome formation was initiated by D2R overactivation with quinpirole, the 
110 
 
SQSTM1 was unable to be degraded, suggesting that autophagic clearance was 
inhibited in primary striatal neurons. The findings in the present study are supported 
by the previous study in which dopamine treatment can also increase the amount of 
LC3-II and SQSTM1 in N2a cells leading to the failure of autophagosome 
degradation (da Luz et al., 2015). Another study also reported that overactivation 
of D2R inhibits autophagy, causing the misfolding and aggregation of the mutated 
huntingtin protein in neuroblastoma cells (Vidoni et al., 2016). A recent study 
reported that the developing schizophrenia rodent model exhibits an elevated 
expression of SQSTM1 in the prefrontal cortex, suggesting that autophagy is 
deficient in schizophrenic subjects (Sumitomo et al., 2018). Akira Sawa et. al. also 
proposed that elevated SQSTM1 may be a novel mechanism underlying synaptic 
functions and cognitive impairment in neurological and neuropsychiatric disorders 
(Tomoda et al., 2019). The present study reported that D2R overactivation damaged 
neurite growth concomitantly with incompletion of mitophagy. Taken together, our 
findings indicate that the inhibited autophagic clearance may play a role in neurite 
impairment caused by D2R overactivation.  
In conclusion, this study elucidates that D2R overactivation damages mitochondria 
and inhibits ROS-mediated mitophagy. The identification of mitochondrial D2R 
may provide a new target for treating neurite deficits, and oxidative stress occurred 
in schizophrenia. 
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5.1 Overall Discussion and Conclusions 
This thesis demonstrates that neurite impairment caused by D2R overactivation is 
associated with the increased D2R-DISC1 complex formation and incomplete 
mitophagy. Prevention of neurite damage by antipsychotic drugs and cell-
penetrating peptide of the D2R-DISC1 complex is also examined in this thesis. This 
chapter will begin by reviewing the significant findings from each chapter and then 
provide a general discussion of the key findings in my Ph.D. project.  
This study firstly discovered the unrecognized signaling pathway where neuronal 
impairment caused by D2R overactivation is through D2R-DISC1 complex 
formation. The excessive formation of the D2R-DISC1 complex decreased the 
phosphorylation of Akt and GSK-3β in cortical neurons. This study further showed 
that the downregulation of GSK-3β phosphorylation occurs in cortical pyramidal 
neurons. Although both atypical antipsychotic drug aripiprazole and typical 
antipsychotic drug haloperidol prevented neurite lesion, aripiprazole displayed 
better protection on the neurite length than haloperidol. Using DISC1 mutation 
mice, this study also demonstrated that haloperidol and aripiprazole prevented 
neurite impairment through DISC1. 
This thesis has also contributed with the first description that TAT-D2pep disrupted 
the interaction between D2R and DISC1 to prevent neurite lesion, suggesting this 
complex would be a potential therapeutic target in treating neurite deficits. Finally, 
for the first time, this study reported that mitochondrial D2R existed on the neurite 
of primary striatal neurons. This study also demonstrated that mitophagy inhibition 
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might be another mechanism underlying membrane and mitochondrial D2R over-
activation.  
Overall, these findings have provided extensive new knowledge on the mechanism 
of D2R in regulating neuroplasticity. We have also addressed several gaps in the 
literature by identifying neuronal D2R-DISC1 complex and mitochondrial D2R 
that can underlie D2R signaling in neuronal protection. The main findings of this 




Table 5.1： Summary of main findings in cortical neurons 
 
                                Treatment  
 
            Parameter 
Quinpirole Quinpirole Quinpirole   Quinpirole Quinpirole Quinpirole 















Neuronal Morphology               
Neurite length in cortical neuron ↓*** ↑### ↑### ↓*** ↓*** NSC# NSC# 
Neurite Branches in cortical neuron ↓*** ↑## ↑### ↓*** ↓*** NSC# ↑# 
Synaptophysin protein in cortical neuron ↓*** ↑# ↑## ↓*** ↓*** NSC# NSC# 
PSD-95 protein in cortical neuron ↓*** NSC# ↑### ↓*** ↓*** NSC# NSC# 
D2R-DISC1 Complex              
D2R-DISC1 complex in cortical neuron ↑*** ↓### ↓### NSC NSC NSC NSC 
D2R Signaling Pathway              
pAkt Ser 473 protein in cortical neuron ↓*** NSC# ↑# ↓*** ↓*** NSC# NSC# 
pAkt Thr 308 protein in cortical neuron ↓***  NSC# ↑### ↓*** ↓*** NSC# ↑# 
Total Akt in cortical neuron NSC* NSC# NSC# NSC* NSC* NSC# NSC# 
pGSK3β Ser9 in cortical neuron ↓*** NSC#  ↑### ↓*** ↓*** NSC# NSC# 
pGSK3β Ser9 intensity in cortical pyramidal neuron ↓***   ↓* ↓***   
Total GSK3β in cortical neuron NSC NSC NSC NSC NSC   



















Neuronal Morphology       
Neurite length in striatal neuron ↓*** ↑### NSC# 
Neurite branches in striatal neuron ↓** ↑### NSC# 
Dendritic spine dendity in striatal neuron ↓** ↑# NSC# 
Synaptophysin density on neurite in striatal neuron ↓*** ↑### NSC# 
PSD-95 density on neurite in striatal neuron ↓*** ↑### NSC# 
D2R-DISC1 complex    
D2R-DISC1 complex in striatal neuron ↑** ↓### NSC# 
Distance between D2R and DISC1 in dendritic spine ↓**** ↑#### NSC# 
D2R nanocluster diameter NSC* NSC* NSC* 
DISC1 nanocluster diameter NSC* NSC* NSC* 
Number of D2R nanocluster in dendritic spine ↓** ↑## NSC# 
Number of DISC1 nanocluster in dendritic spine ↓**** ↑#### NSC# 
D2R signalling pathway    
pGSK3β Ser9 intensity in striatal interneuron ↓*** ↑### NSC# 
NPY in striatal interneuron ↓*** ↑### NSC# 
ROS    
Mitochondrial cristae length by Cryo-ET ↓   
Mitochondrial cristae size by Cryo-ET ↓   
Intracellular ROS in striatal neuron ↑***   
Mitochondrial ROS in striatal neuron ↑***   
Mitochondrial ROS in isoalted mitochondria ↑   
MDA level ↑*     
Mitophagy    
Colocalization of LC3-II and mitochondria ↑**   
SQSTM1 protein in HEK-293 cell ↑*   
SQSTM1 intensity in strialtal neuron ↑   




Table 5.3：  Summary of main findings in HEK-293 cells (D2R and DISC1 
plasmid transfected) 
 
                    Treatment  
 
 Parameter 
Quinpirole Quinpirole Quinpirole 







Neuronal Morphology       
Synaptophysin protein in HEK-293 cell ↓** ↑# NSC# 
PSD-95 protein in HEK-293 cell ↓** ↑# NSC# 
D2R-DISC1 Complex    
D2R-DISC1 complex in HEK-293 ↑*** ↓## NSC# 
D2R Signaling Pathway    
pGSK3β Ser9 protein in HEK-293 cell ↓*** ↑# NSC# 
NPY in HEK-293 cell ↓* ↑# NSC# 
Mitophagy    
LC3-I in HEK-293 cell NSC   
LC3-II in HEK-293 cell ↑**   
LC3-II / LC3-I in HEK-293 cell ↑**   
SQSTM1 protein in HEK-293 cell ↑*   
Identification of mitochondrial D2R       
 
 
Abbreviations: D2R:Dopamine D2 receptor; DISC1: Disrupted-in-Schizophrenia 
1; LI: Locus impairment; GSK3β: Glycogen synthase kinase 3 beta; Akt: Protein 
kinase B (PKB); NPY: Neuropeptide Y; Cryo-ET: Cryo electron tomography; 
ROS: Reactive oxygen species; MDA: Malondialdehyde; LC3: Microtubule-
associated proteins 1A/1B light chain 3; SQSTM1: Sequestosome 1; ↑: increase; 
↓:decrease; NSC*: no significant change versus control group; NSC#: no 
significant change versus quinpirole group; *P< 0.05 versus control; **P< 0.01 
versus control; ***P< 0.001 versus control; ****P< 0.0001 versus control;  #P< 
0.05 versus quinpirole; ##P< 0.01 versus quinpirole; ###P< 0.001 versus 
quinpirole; ####P< 0.0001 versus quinpirole;  
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5.1.1 Overall Discussion of the Findings 
In Chapter 2, it is the first time to demonstrate that D2R overactivation damages 
neural networks through the excessive formation of the D2R-DISC1 complex. 
Quinpirole induced D2R overactivation has been widely used as a model to study 
the mechanisms of schizophrenia and other psychiatric disorders (Kostrzewa et al., 
2016, Stuchlik et al., 2016). The current research reveals that quinpirole 
significantly reduces neurite length and branches by increasing the formation of the 
D2R-DISC1 complex.  It has been previously reported that quinpirole at 100 µM 
inhibits neurite outgrowth, while quinpirole at 1 µM mainly promotes axonal 
outgrowth, suggesting that D2R activation affects neuronal morphology in a 
concentration-dependent manner (Reinoso et al., 1996). In addition, the excessive 
formation of the D2R-DISC1 complex decreased the expressions of synaptophysin 
and PSD-95, suggesting that the increased D2R-DISC1 complex could weaken 
synaptic connections. Chapter 2 also indicates that DISC1 is necessary for neurite 
outgrowth by using cultured cortical neurons from DISC1-LI mice. In DISC1-LI 
mice, the exons from 1 to 3 in the N-terminal of DISC1 are deleted, which makes 
DISC1 lose function and abolishes DISC1 binding with D2R. Thus, I did not 
observe significant FRET signals from the D2R-DISC1 complex in cortical neurons 
of DISC1-LI mice. It has been demonstrated that DISC1 mutation mice display 
enhanced dopamine function associated with psychiatric disorders (Tomoda et al., 
2016). In fact, DISC1 mutation shows no effect on D2R density in the striatum, but 
a remarkable rise in the affinity of D2R is observed in rats (Trossbach et al., 2016). 
These crucial pieces of evidence explain my study that the Akt-GSK3 signaling 
could be suppressed by DISC1-LI induced D2R hyperfunction. In addition, DISC1, 
as a scaffolding protein, promotes neuronal development by interacting with other 
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signaling molecules, such as GSK3β (Ishizuka et al., 2006, Lipina et al., 2011). 
Interestingly, my study demonstrated that quinpirole treatment disassociates the 
interaction between DISC1 and GSK3β, leading to more DISC1 binds to D2R in 
cortical neurons. Cortical neurons of DISC1-LI mice showed decline in neurite 
length and branches, suggesting that the functional domain of DISC1 plays a 
critical role in maintaining the neuronal morphology. This study provided novel 
proof that dysfunction of the N-terminal of DISC1 or excessive D2R-DISC1 
complex results in neurite impairment.  
The findings of Chapter 2 further indicate that haloperidol and aripiprazole have 
different mechanisms to prevent neurite lesions caused by the excessive D2R-
DISC1 complex formation. The typical and atypical antipsychotic drugs displayed 
different neuroprotective effects in the developing brain (Lieberman et al., 2008). 
Clinically, aripiprazole has better efficacy in treating cognitive symptoms than 
haloperidol in the onset of schizophrenia (Girgis et al., 2011). Further, haloperidol 
has been shown to be cytotoxic to neurons in a concentration-dependent manner 
via oxidative stress (Gasso et al., 2012). In the current study, I first identified that 
both haloperidol and aripiprazole could block the quinpirole-induced formation of 
the D2R-DISC1 complex in cultured cortical neurons. Haloperidol and aripiprazole 
restored the neurite length and branches to normal by disassociating the interaction 
between D2R and DISC1, suggesting the D2R-DISC1 complex mediates the 
neuroprotection by haloperidol and aripiprazole. However, haloperidol showed no 
effects on the Akt-GSK3 signaling pathway compared with aripiprazole, suggesting 
that haloperidol and aripiprazole affect neuroplasticity via different pathways. It 
has been previously reported that aripiprazole but not haloperidol prefers to target 
on β-arrestin2 dependent signaling cascades, which leads to primarily affecting the 
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activity of GSK3β (Masri et al., 2008, Urs et al., 2017). Importantly, for cultured 
cortical neurons from DISC1-LI mice, neither haloperidol nor aripiprazole could 
prevent neurite lesion induced by quinpirole. This result indicates that DISC1 is 
necessary for haloperidol and aripiprazole to protect neurite, which may provide a 
novel target when designing antipsychotic drugs.   
In Chapter 3, the study found that D2R interacts with DISC1 within dendritic 
spines, which is related to the dendritic spine density of cultured striatal neurons. 
A previous study observed a reduction of spine density in a schizophrenia-like 
animal model (Solis et al., 2009). Accumulating evidence has indicated that 
protein-protein interactions exist in the synapse to affect synaptic functions. It has 
been recently reported that the altered interaction between nanomodules within 
synapse could influence the size and density of dendritic spines (Hruska et al., 
2018). Here, using STORM imaging, the existence of D2R and DISC1 is firstly 
revealed in a nanocluster type instead of a single molecule. Consistent with recent 
super-resolution findings, D2R forms oligomers in higher-order in the mouse brain 
(Onishi et al., 2018). In addition, the diameter of D2R and DISC1 nanoclusters was 
not changed by quinpirole. In the current study, I demonstrated that quinpirole 
decreased the distance between D2R and DISC1 nanoclusters to form D2R-DISC1 
complex in a single dendritic spine. STORM imaging showed that the complex 
formed by D2R and DISC1 could be potential synaptic nanomodules. FRET is a 
widely used fluorescence technique to study protein-protein interaction within cells. 
In Chapter 2, I used FRET technique to quantify the formation of D2R and DISC1 
complex after drugs treatment. This study reports the relationship between the 
actual distance of proteins and FRET occurrence, which is the first time that FRET 
has been elucidated from a nanoscale perspective. FRET has been proven to be an 
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invaluable technique to detect protein interactions in living cells. And most of the 
super-resolution microscopy methods are also suitable for living cells. Thus, it is 
very interesting to observe at high-resolution where and when the protein 
interactions take place by applying FRET in a super-resolution setting. In addition, 
this study further revealed that disassociating the D2R-DISC1 complex by TAT-
D2pep restores the dendritic spine density of cultured neurons, indicating that 
synaptic D2R-DISC1 complex could be involved in the synaptic formation. Since 
dendritic spines have different morphologies (thin, stubby, and mushroom) 
associated with learning and memory (Bourne and Harris, 2007), it is interesting to 
investigate that the role of synaptic D2R-DISC1 complex in spine morphology. 
Similar to the findings in Chapter 2, TAT-D2pep also prevented neurite lesion 
induced by the excessive formation of D2R–DISC1 complexes by upregulating 
synaptophysin and PSD-95 level. During the process of neurodevelopment, 
synaptophysin and PSD-95 serve as essential regulators (Park et al., 2013, Zhang 
et al., 2016). Increasing interaction between PSD-95 and DISC1 facilitates 
dendritic spine growth (Hayashi-Takagi et al., 2010). As discussed in Chapter 2, 
the excessive D2R-DISC1 complex formation decreases the GSK3β-DISC1 
interaction. Here, when more DISC1 binds to D2R by quinpirole, less DISC1 may 
interact with PSD-95, leading to the reduction of dendritic spine density in cultured 
striatal neurons. The results of synaptophysin and PSD-95 in Chapter 2 and Chapter 
3 indicates that synaptophysin and PSD-95 mediates the effect of D2R-DISC1 
complex on neuronal morphology. Striatal D2R hyperactivity is associated with the 
deficits of conditional learning, temporal precision, and working memory in mice 
selectively overexpress D2R in the striatum (Kellendonk et al., 2006). Although 
schizophrenia patients also have similar cognitive deficits (Gold et al., 2000, 
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Carroll et al., 2008, Tek et al., 2002), it may not be appropriate to superimpose the 
animal data to humans. More human research is required in this regard. In addition, 
findings of Chapter 3 originally reported that D2R overactivation directly decreased 
NPY expression by forming excessive D2R-DISC1 complexes, which were 
blocked by TAT-D2pep. Previously, it has been reported that D2R overactivation 
caused by amphetamine remarkably reduce NPY expression in rat, suggesting that 
NPY is regulated by D2R (Kuo, 2003). Here I provided further evidence that D2R 
regulates NPY expression through the D2R-DISC1 complex. NPY has been found 
mainly existed in GABAergic interneurons and contributes to neuroplasticity and 
synaptic communications in the brain (Gotzsche and Woldbye, 2016). Our lab 
recently reported that the reduction of NPY expression caused by D2R antagonist 
haloperidol in striatal GABAergic interneurons leads to neuronal damage (Hu et al., 
2018). This finding further explains that why haloperidol is not good in protecting 
neurite compared with TAT-D2pep even though both haloperidol and TAT-D2pep 
can block D2R-DISC1 complex formation. Our lab has previously demonstrated 
that the administration of atypical antipsychotic drugs olanzapine remarkably 
upregulated mRNA and protein expression levels of NPY in the schizophrenia rat 
model (Huang et al., 2006, Lian et al., 2014). The findings of Chapter 3 suggest 
that NPY is associated with the neuroprotective effects of TAT-D2pep on neuronal 
morphology of cultured striatal neurons.   
In Chapter 4, this study revealed that oxidative stress and incomplete mitophagy 
are involved in the neurite impairment caused by D2R overactivation in striatal 
neurons. This thesis has shown that over activating D2R significantly damaged 
neural networks in Chapter 2 and Chapter 3. Since neuronal growth is a highly 
energy-demanding process that majorly depends on dendritic mitochondria, I 
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assumed that D2R overactivation might result in mitochondrial damage. In the 
current study, our cryo-ET analysis firstly provides strong evidence that 
overactivation of D2R damaged mitochondrial ultrastructure in primary striatal 
neurons. This study was the first to report that mitochondrial cristae were damaged 
after D2R was over-stimulated in striatal neurons, indicating the important role of 
D2R in controlling mitochondrial integrity. A similar result was also reported that 
more than 90% of mitochondria showed damaged cristae in dopamine treated 
human neuroblastoma cells (Zilocchi et al., 2018). Further experiments needed to 
study the effects of D2R activation on mitochondrial function, like ATP synthesis. 
Although many studies have already revealed that dopamine causes oxidative stress 
through dopamine receptors, the role of D2R in ROS production is not fully 
explained. The mitochondrion is a major site for ROS production, and unrestrained 
ROS accumulation can further injure mitochondria. This study confirmed that 
overactivation of D2R by its specific agonist increased mitochondrial ROS 
production in neurons and isolated mitochondria, indicating hyperdopaminergia 
induced ROS generation is conceivably through D2R. To my knowledge, this is the 
first time to reveal the role of D2R in regulating oxidative stress in striatal neurons. 
Interestingly, neuronal cultures exposed to dopamine show oxidative stress as well 
as a significant decrease in dendritic spines (Beckhauser et al., 2016). The current 
study implied that excessive ROS generation might underly the mechanism of 
neuronal impairment caused by D2R. The results may be responsible for part of the 
symptoms of schizophrenia, particularly those involving cognitive functions 
(Bitanihirwe and Woo, 2011). At the initial stage of mitophagy, quinpirole 
promoted autophagosome formation through an un-regulating LC3-II level. p62 is 
the receptor protein that delivers the injured organelles and potentially toxic protein 
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aggregates to autophagosomes (Vidoni et al., 2016). The increased expression of 
p62 suggests that autophagic clearance or transportation is impaired (Su et al., 
2018). Although the autophagosome formation was initiated, this study reported 
the expression of p62 was up regulated following quinpirole treatment, indicating 
that autophagic process was inhibited. Consistent with previous study, dopamine 
treatment can also increase amount of LC3-II and p62/SQSTM1 in N2a cells 
leading to the failure of autophagosome degradation (da Luz et al., 2015).  Akira 
Sawa et. al. proposed that elevated p62 pathology may serve as a mechanism 
underlying synaptic functions and cognitive impairment in neurological and 
neuropsychiatric disorders (Tomoda et al., 2019). Taken together, this study 
revealed that the inhibited autophagic flux might be a potential consequence of D2 
receptor overactivation. Notably, I originally demonstrated that D2R located on the 
neuronal mitochondrion and regulated mitochondrial ROS production. Activation 
or inhibition of mitochondrial GPCR appears to affect mitochondrial processes 
such as ROS production and cell apoptosis (Jong et al., 2018). Importantly, I 
visualized that D2R is co-localized with mitochondria on the neurite of striatal 
neurons, suggesting mitochondrial D2R may have a role in regulating neurite 
growth. Taken together, understanding D2R subcellular localization can strongly 
contribute to receptor function and even disease pathology.  
5.1.2 Proposed mechanisms of D2R overactivation induced neurite 
impairment in different cell models 
The main aim of this dissertation is to understand how D2 overactivation would 
affect neurite outgrowth and dendritic spine formation. The rationale for this work 
is based on evidence that D2R overactivation exists in psychiatric disorder 
accompanied by neuronal damage. The findings from the studies provide valuable 
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insights for the mechanism through different cell models. As discussed in Chapter 
2, the excessive D2R-DISC1 complex formation was firstly reported to inhibit 
neurite outgrowth in cortical neurons. The cerebral pathology of schizophrenia has 
been studied extensively in recent decades. Deficits in neurite density are 
fundamental to the reduction in cerebral volume in early psychosis (Rae et al., 
2017). Findings of Chapter 2 elucidate that the excessive D2R-DISC1 is involved 
in the neurite deficits of cortical neurons, suggesting that the D2R-DISC1 could be 
a pharmacological target to rescue neurons. Subsequently, the intracellular 
signaling pathway of D2R was inhibited by over activating D2R, including reduced 
expression of phosphorylated Akt and GSK3β. Interestingly, the reduced 
phosphorylation of GSK3β could further disassociate GSK3β-DISC1 complex 
leading to more DISC1 binds to D2R. Finally, the excessive D2R-DISC1 complex 
caused by D2R overactivation damaged neurite of cortical neurons. To prevent 
neurite impairment caused by D2R overactivation, this study further applied typical 
antipsychotic drug haloperidol and atypical antipsychotic drug aripiprazole, which 
are also D2R antagonists. Surprisingly, although haloperidol and aripiprazole 
blocked quinpirole induced D2R-DISC1 formation, they displayed different effects 
on Akt-GSK3β signaling and synaptic proteins. Haloperidol had no effects on the 
phosphorylation of Akt and GSK3β, suggesting that the D2R independent signaling 
pathway is not influenced by typical antipsychotic drug haloperidol. Furthermore, 
aripiprazole reversed the quinpirole-induced reduction of synaptophysin and PSD-
95, while haloperidol had no effect on PSD-95 expression. Studies have shown that 
both haloperidol and aripiprazole can stimulate mTOR signaling (Bowling et al., 
2014, Ishima et al., 2012). Activation of mTOR signaling is associated with neurite 
outgrowth, branching, and spine density (Kim et al., 2009, Speranza et al., 2015, 
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He et al., 2019). Conversely, mTOR inhibitor rapamycin prevents neurite 
outgrowth-induced by haloperidol and aripiprazole (Bowling et al., 2014, Ishima et 
al., 2012). This may explain the difference in PSD-95 expression between the two 
drugs, but the same neurite growth effect observed in this study.  
As DISC1 is essential in brain neuroplasticity, this study also examined whether 
DISC1 would mediate the effects of haloperidol and aripiprazole on 
neuroplasticity. The binding site of D2R and DISC1 is abolished in DISC1-LI mice. 
Notably, neither haloperidol nor aripiprazole protected neurite of cultured DISC1-
LI cortical neurons, displaying no alternations in Akt-GSK3β signaling and 
synaptic proteins compared with quinpirole treated group. This study for the first 
time demonstrates that haloperidol and aripiprazole protect neuroplasticity via 
DISC1, which may provide further evidence for designing novel antipsychotic 
drugs. Further, in vivo experiments need to be performed to study whether 
haloperidol and aripiprazole could ameliorate cognitive decline in the 











(Figure legend on next page)  
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Figure 5.1 Proposed mechanisms of D2R-DISC1 induced neurite impairment 
in cultured cortical neurons. In cortical neurons of wild type mice, ①D2R 
overactivation induced by quinpirole increased the D2R-DISC1 complex 
formation. Both haloperidol and aripiprazole blocked the D2R-DISC1 complex 
formation induced by quinpirole. Administration of 100 µM quinpirole for 48 hours 
significantly inhibited ②Akt phosphorylation on Thr308 and Ser473 and 
③GSK3β phosphorylation on Ser9. ④The declined phosphorylation of GSK3β 
Ser9 then led to disassociation of GSK3β-DISC1 complex, which lets more DISC1 
bind to D2R. Aripiprazole and haloperidol displayed different effects on Akt-GSK3 
signaling. Aripiprazole prevented the reduction of ②Akt phosphorylation on 
Thr308 and Ser473 and ③GSK3β phosphorylation on Ser9. The elevated 
formation of the D2R-DISC1 complex caused by quinpirole significantly inhibited 
the expression of ⑤synaptophysin and ⑥PSD-95. Aripiprazole reversed the 
quinpirole-induced reduction of ⑤synaptophysin and ⑥PSD-95, while 
haloperidol has no effect on PSD-95 expression. Finally, the excessive formation 
of the D2R-DISC1 complex caused by quinpirole significantly decreased ⑦neurite 
length and ⑧branches in cortical neurons. In cortical neurons of DISC1-LI mice, 
⑨the D2R-DISC1 complex formation is abolished because the binding site on 
DISC1 is deleted. Quinpirole exacerbates the decreased phosphorylation of ⑩Akt 
on Thr308 and Ser473 and ⑪GSK3β on Ser9 compared with wild type neurons. 
Aripiprazole and haloperidol were unable to fully reverse the phosphorylation of 
⑩Akt on Thr308 and Ser473 and ⑪GSK3β on Ser9. Further, both haloperidol 
and aripiprazole failed to change the decreased expression of synaptic proteins 
⑫synaptophysin and ⑬PSD-95 caused by quinpirole. Finally, haloperidol and 
aripiprazole failed to rescue ⑭neurite impairment in cortical neurons of DISC1-LI 
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mice.   
Abbreviations: Quin: quinpirole at 100 µM; Halo: haloperidol at 10 µM; Ari: 
aripiprazole at 10 µM. D2R: dopamine D2 receptor; SYN: synaptophysin; DISC-
LI: DISC1 locus impairment. Blue arrow: quinpirole treatment; Red arrow: 
pretreatment of haloperidol in the presence of quinpirole at 10 µM. Green arrow: 
pretreatment of aripiprazole in the presence of quinpirole at 10 µM. Yellow arrow: 
cortical neurons of DISC1 locus impairment mice. 
It has been demonstrated that D2R abundantly expresses in the striatum, which 
makes striatal D2R is the major target for antipsychotic drugs. Based on the 
findings in Chapter 1, the thesis further investigated the role of D2R-DISC1 in the 
synaptogenesis of striatal neurons by using super-resolution microscopy. Notably, 
this thesis firstly identified that the interaction between D2R and DISC1 exited in 
a single dendritic spine of striatal neurons, suggesting that the synaptic D2R-DISC1 
complex could be a novel nanomodule consisting of synaptic architecture. As 
discussed in Chapter 2, I used FRET technology to demonstrate whether the D2R-
DISC1 complex was formed, which showed the distance of D2R and DISC1 is less 
than 10 nm. In this study, the STORM images quantified the actual distance of D2R 
and DISC1 nanoclusters in synapses, which provides the possibility of using a 
super-resolution technique to quantify fluorescent-based FRET. The cell-
penetrating peptide, TAT-D2pep, targeted explicitly on separating excessive 
synaptic D2R-DISC1 complex induced by quinpirole. The findings from STORM 
also expanded our understandings that D2R and DISC1 existed in dendritic spines 
with nanoclusters manner instead of single molecular. The density of D2R and 
DISC1 nanoclusters were decreased by quinpirole, which was prevented by cell-
penetrating peptide TAT-D2pep. Further, this study reported that the excessive 
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synaptic D2R-DISC1 complex was accompanied by a reduction in dendritic spine 
density. TAT-D2pep protected dendritic spines, suggesting that the D2R-DISC1 
complex plays an important role in regulating spine formation. In addition, this 
study for the first time reveals that the protective effects of TAT-D2pep on neurite 
is through GSK3β-NPY signaling in striatal interneurons. Accumulating evidence 
indicated that D2R is involved in regulating the mitophagy process in several 
diseases, like Parkinson’s disease. Here, the findings showed that D2R 
overactivation significantly increased intracellular and mitochondrial ROS levels. 
Although the excessive ROS production initiated autophagosome formation, the 
formation of autolysosome was inhibited due to over activating D2R. Interestingly, 
D2R was firstly identified on the mitochondrial membrane. Overactivation of 
mitochondrial D2R led to the decreased number of folded cristae and length of 











Figure 5.2 Proposed mechanisms of D2R-DISC1 induced neurite impairment 
in cultured striatal neurons. In striatal neurons, ①the D2R-DISC1 complex 
formation was significantly increased by quinpirole at 10 µM on neurite and soma. 
Preincubation with TAT-D2pep uncoupled excessive D2R-DISC1 complex 
induced by quinpirole. The excessive D2R-DISC1 complex formation induced by 
quinpirole then decreased the ②GSK3β phosphorylation on Ser9 and ③NPY, 
while TAT-D2pep reversed the declined GSK3β phosphorylation and NPY in 
striatal interneurons. The inhibited GSK3β signaling pathway then led to a 
reduction in the intensity of ④synaptophysin and ⑤PSD-95 on neurite, which was 
reversed by TAT-D2pep. TAT-D2pep protected neurite growth by disrupting the 
D2R-DISC1 complex, increasing GSK3β signaling, and synaptic protein 
expression. In a single dendritic spine of cultured striatal neurons, the interaction 
between D2R and DISC1 was observed by using super-resolution microscopy 
(STORM). ⑥STORM images revealed that the distance between D2R and DISC1 
nanoclusters was reduced in dendritic spines after quinpirole treatment. TAT-
D2pep increased the distance between D2R and DISC1 nanoclusters in the presence 
of quinpirole. In addition, the density of ⑦D2R and ⑧DISC1 nanoclusters were 
decreased after the D2R-DISC1 complex was excessively formed by quinpirole in 
dendritic spines. TAT-D2pep restored the density of D2R and DISC1 nanoclusters 
by decreasing the interaction between D2R and DISC1. Further, the excessive 
formation of the D2R-DISC1 complex in single dendritic spines significantly 
reduced the ⑨spine density, which was reversed by TAT-D2pep. In mitochondria 
of cultured striatal neurons. In addition, D2R overactivation significantly increased 
⑩the intracellular ROS level. Although the excessive ROS production initiated 
⑪autophagosome formation (LC3 II / LC3 I), ⑫the formation of autolysosome 
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(SQSTM1) was inhibited due to over activating D2R. The incomplete mitophagy 
failed to eliminate ROS leading to ⑬MDA accumulation within striatal neurons. 
⑭The excessive D2R-DISC1 complex formation and incomplete mitophagy 
impaired neurite outgrowth. ⑮D2R was firstly identified on the mitochondrial 
membrane. Overactivation of D2R led to ⑯mitochondrial ROS production, 
resulting in ⑰ a decreased number of folded cristae and length of cristae. Thus, 
D2R-DISC1 complex induced oxidative stress may also involve in neurite lesion. 
Abbreviation: Quin: quinpirole at 10 µM; TAT-D2: TAT-D2pep at 10 µM. ROS: 
reactive oxygen species. Blue arrow: quinpirole treatment; Orange arrow: 
Pretreatment of TAT-D2pep in the presence of quinpirole at 10 µM. 
To specifically determine which signaling molecule is influenced by the D2R-
DISC1 complex, this study constructed a HEK-293 cell model that was transfected 
with D2R and DISC1 plasmids.  Consistent with the findings in cortical neurons 
and striatal neurons, D2R overactivation induced by quinpirole significantly 
increased the formation of the D2R-DISC1 complex. D2R antagonist haloperidol 
and cell-penetrating peptide TAT-D2pep disrupted the excessive formation of the 
D2R-DISC1 complex. Increased interaction of D2R and DISC1 induced by 
quinpirole further decreased the GSK3β phosphorylation on Ser 9. The decreased 
GSK3β phosphorylation induced by D2R-DISC1 interaction was reversed by TAT-
D2pep but not D2R antagonist haloperidol. The expression of NPY was inhibited 
by quinpirole, which can be restored to the control level by TAT-D2pep. Finally, 
the expressions of synaptophysin and PSD-95 were reduced by the excessive D2R-
DISC1 complex, which was restored to the control level by TAT-D2pep. In HEK-
293 cells, I also reported that the excessive D2R-DISC1 complex resulted in 
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incomplete mitophagy by failing to degrade SQSTM1.  
 
 
Figure 5.3 TAT-D2pep reverses the reductions of synaptic proteins and 
autophagy induced by D2R-DISC1 in HEK-293 cells. In HEK-293 cells, the 
D2R-eGFP and DISC1 mCherry constructs were transfected to generate a cell 
model for studying the interaction between D2R and DISC1. ①D2R overactivation 
induced by quinpirole increased the formation of D2R-DISC1 complex more than 
three folds. The excessive formation of the D2R-DISC1 complex was blocked by 
D2R antagonist haloperidol and cell-penetrating peptide TAT-D2pep. Further, 
quinpirole failed to induce D2R-DISC1 complex formation when the specific 
binding site on D2R was deleted. ②Increased D2R-DISC1 complex induced by 
quinpirole further decreased the GSK3β phosphorylation on Ser 9. The decreased 
GSK3β phosphorylation caused by the D2R-DISC1 complex was reversed by TAT-
D2pep but not D2R antagonist haloperidol. ③The expression of NPY was 
inhibited by quinpirole, which can be restored to the control level by TAT-D2pep. 
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Finally, the expressions of ④synaptophysin and ⑤PSD-95 were reduced by the 
excessive D2R-DISC1 complex, which was restored to the control level by TAT-
D2pep.  ⑥ Although the excessive D2R-DISC1 initiated autophagosome 
formation (LC3 II / LC3 I), ⑦the formation of autolysosome (SQSTM1) was 
inhibited due to the excessive D2R-DISC1 complex. 
Abbreviation: Quin: quinpirole at 10 µM; TAT-D2: TAT-D2pep at 10 µM. Blue 
arrow: quinpirole treatment; Orange arrow: Pretreatment of TAT-D2pep in the 





5.1 Recommendations for Future Research 
According to the findings, the recommendations are made as follows: 
1. This study investigated the effect of TAT-D2pep on neuroprotection using cell-
based models only. Although the results were promising, a preclinical trial will be 
necessary to verify the neuroprotective effect and study the consequence of 
behavioral changes in rodents after TAT-D2pep treatment. It is recommended to 
use the rodent models with dopamine hyperactivity relevant to schizophrenia 
together with appropriate controls. 
2. Dendritic spines are highly dynamic, which are re-categorized by super-
resolution microscopy into two major types: thin and mushroom. Thin spines are 
more flexible ‘learning spines,’ whereas mushroom spines are more stable 
‘memory spines’ (Bourne and Harris, 2007). Although we were the first to link 
D2R-DISC1 complex to dendritic pine formation in this study, it is still unknown 
whether this complex will influence thin and mushroom spine dynamics.  
3. It is interesting to observe D2R locates on mitochondrion. Due to the access to 
D2R knockout mice and time limitation, we were unable to clarify the existence of 
mitochondrial D2R in vivo. A future study could further investigate the D2R is 
located on the inner or outer membrane of mitochondrion by using the Cryo-EM 
technique.  
4. Last, the measurements of neurite length in this study are from a two-dimensional 
surface, which may not fully reflect how neurons may grow in the actual 
environment. Thus, the three-dimensional culturing device may be applied in future 
research to confirm these neuroprotective effects. 
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5.  It is well known that excessive dopamine activity can cause an onset of 
psychosis. This is reported in several psychiatric disorders, including 
schizophrenia, bipolar disorder at manic state, obsessive-compulsive disorder, and 
some drug abuses. Based on my study, it is likely that hyperdopaminergic activity 
will cause an abnormal D2R-DISC1 complex; however, such assumptions will 




Neurite deficits result in the alternation in neural connection and psychotic 
symptoms in psychiatric disorders. Here the findings of the present thesis have 
demonstrated that the excessive D2R-DISC1 complex caused by D2R 
overactivation had remarkable effects on the neuroplasticity of cortical and striatal 
neurons. The abnormal D2R-DISC1 complex caused downregulation of 
phosphorylated Akt and GSK3β, synaptic proteins, and NPY in neurons. This study 
also provided evidence that haloperidol showed less protection on neurite than 
aripiprazole, mainly because haloperidol had no effects on the D2R intracellular 
signaling pathway. The DISC1-LI mutant made the neuroprotective effects of 
haloperidol and aripiprazole invalid. The new antipsychotic peptide TAT-D2pep 
was demonstrated to protect neuroplasticity and synapse. This study initially 
demonstrated that D2R existed on the mitochondrial membrane of neurons. 
Overactivation of cellular and mitochondrial D2R significantly increased ROS 
production, which resulted in incomplete mitophagy.  Taken together, the D2R-
DISC1 complex and mitochondrial D2R might be potential therapeutic targets for 
treating neurite deficits in schizophrenia patients.  
143 
 
List of References 
 
ACQUIER, A. B., MORI SEQUEIROS GARCIA, M., GOROSTIZAGA, A. B., 
PAZ, C. & MENDEZ, C. F. 2013. Reactive oxygen species mediate dopamine-
induced signaling in renal proximal tubule cells. FEBS Lett, 587, 3254-60. 
AHLUWALIA, A., BRZOZOWSKA, I. M., HOA, N., JONES, M. K. & 
TARNAWSKI, A. S. 2018. Melatonin signaling in mitochondria extends beyond 
neurons and neuroprotection: Implications for angiogenesis and 
cardio/gastroprotection. Proc Natl Acad Sci U S A, 115, E1942-E1943. 
ANGLIN, R., ROSEBUSH, P. & MAZUREK, M. 2012. Psychotropic 
medications and mitochondrial toxicity. Nat Rev Neurosci, 13, 650. 
ASHRAFI, G., SCHLEHE, J. S., LAVOIE, M. J. & SCHWARZ, T. L. 2014. 
Mitophagy of damaged mitochondria occurs locally in distal neuronal axons and 
requires PINK1 and Parkin. J Cell Biol, 206, 655-70. 
AVELEIRA, C. A., BOTELHO, M., CARMO-SILVA, S., PASCOAL, J. F., 
FERREIRA-MARQUES, M., NOBREGA, C., CORTES, L., VALERO, J., 
SOUSA-FERREIRA, L., ALVARO, A. R., SANTANA, M., KUGLER, S., 
PEREIRA DE ALMEIDA, L. & CAVADAS, C. 2015. Neuropeptide Y stimulates 
autophagy in hypothalamic neurons. Proc Natl Acad Sci U S A, 112, E1642-51. 
BATES, M., JONES, S. A. & ZHUANG, X. 2013. Stochastic optical 
reconstruction microscopy (STORM): a method for superresolution fluorescence 
imaging. Cold Spring Harb Protoc, 2013, 498-520. 
BEAULIEU, J. M. & GAINETDINOV, R. R. 2011. The physiology, signaling, 
and pharmacology of dopamine receptors. Pharmacol Rev, 63, 182-217. 
144 
 
BEAULIEU, J. M., GAINETDINOV, R. R. & CARON, M. G. 2007. The Akt-
GSK-3 signaling cascade in the actions of dopamine. Trends Pharmacol Sci, 28, 
166-72. 
BEAULIEU, J. M., GAINETDINOV, R. R. & CARON, M. G. 2009. Akt/GSK3 
signaling in the action of psychotropic drugs. Annu Rev Pharmacol Toxicol, 49, 
327-47. 
BEAULIEU, J. M., SOTNIKOVA, T. D., MARION, S., LEFKOWITZ, R. J., 
GAINETDINOV, R. R. & CARON, M. G. 2005. An Akt/beta-arrestin 2/PP2A 
signaling complex mediates dopaminergic neurotransmission and behavior. Cell, 
122, 261-73. 
BECKHAUSER, T. F., FRANCIS-OLIVEIRA, J. & DE PASQUALE, R. 2016. 
Reactive Oxygen Species: Physiological and Physiopathological Effects on 
Synaptic Plasticity. J Exp Neurosci, 10, 23-48. 
BEN-SHACHAR, D. 2002. Mitochondrial dysfunction in schizophrenia: a 
possible linkage to dopamine. J Neurochem, 83, 1241-51. 
BENARD, G., MASSA, F., PUENTE, N., LOURENCO, J., BELLOCCHIO, L., 
SORIA-GOMEZ, E., MATIAS, I., DELAMARRE, A., METNA-LAURENT, M., 
CANNICH, A., HEBERT-CHATELAIN, E., MULLE, C., ORTEGA-
GUTIERREZ, S., MARTIN-FONTECHA, M., KLUGMANN, M., 
GUGGENHUBER, S., LUTZ, B., GERTSCH, J., CHAOULOFF, F., LOPEZ-
RODRIGUEZ, M. L., GRANDES, P., ROSSIGNOL, R. & MARSICANO, G. 
2012. Mitochondrial CB(1) receptors regulate neuronal energy metabolism. Nat 
Neurosci, 15, 558-64. 
145 
 
BERGSON, C., LEVENSON, R., GOLDMAN-RAKIC, P. S. & LIDOW, M. S. 
2003. Dopamine receptor-interacting proteins: the Ca2+ connection in dopamine 
signaling. Trends in Pharmacological Sciences, 24, 486-492. 
BEUREL, E., GRIECO, S. F. & JOPE, R. S. 2015. Glycogen synthase kinase-3 
(GSK3): regulation, actions, and diseases. Pharmacol Ther, 148, 114-31. 
BHUKEL, A., BEUSCHEL, C. B., MAGLIONE, M., LEHMANN, M., JUHASZ, 
G., MADEO, F. & SIGRIST, S. J. 2019. Autophagy within the mushroom body 
protects from synapse aging in a non-cell autonomous manner. Nat Commun, 10, 
1318. 
BITANIHIRWE, B. K. & WOO, T. U. 2011. Oxidative stress in schizophrenia: 
an integrated approach. Neurosci Biobehav Rev, 35, 878-93. 
BJØRKØY, G., LAMARK, T., PANKIV, S., ØVERVATN, A., BRECH, A. & 
JOHANSEN, T. 2009. Chapter 12 Monitoring Autophagic Degradation of 
p62/SQSTM1. Autophagy in Mammalian Systems, Part B. 
BOURNE, J. & HARRIS, K. M. 2007. Do thin spines learn to be mushroom 
spines that remember? Curr Opin Neurobiol, 17, 381-6. 
BOWLING, H., ZHANG, G., BHATTACHARYA, A., PEREZ-CUESTA, L. M., 
DEINHARDT, K., HOEFFER, C. A., NEUBERT, T. A., GAN, W. B., KLANN, 
E. & CHAO, M. V. 2014. Antipsychotics activate mTORC1-dependent 
translation to enhance neuronal morphological complexity. Sci Signal, 7, ra4. 
BRADSHAW, N. J. & PORTEOUS, D. J. 2012. DISC1-binding proteins in neural 
development, signalling and schizophrenia. Neuropharmacology, 62, 1230-41. 
BRENNER-LAVIE, H., KLEIN, E., ZUK, R., GAZAWI, H., LJUBUNCIC, P. & 
BEN-SHACHAR, D. 2008. Dopamine modulates mitochondrial function in 
146 
 
viable SH-SY5Y cells possibly via its interaction with complex I: relevance to 
dopamine pathology in schizophrenia. Biochim Biophys Acta, 1777, 173-85. 
BRISCH, R., SANIOTIS, A., WOLF, R., BIELAU, H., BERNSTEIN, H. G., 
STEINER, J., BOGERTS, B., BRAUN, K., JANKOWSKI, Z., 
KUMARATILAKE, J., HENNEBERG, M. & GOS, T. 2014. The role of 
dopamine in schizophrenia from a neurobiological and evolutionary perspective: 
old fashioned, but still in vogue. Front Psychiatry, 5, 47. 
BURBULLA, L. F., SONG, P., MAZZULLI, J. R., ZAMPESE, E., WONG, Y. 
C., JEON, S., SANTOS, D. P., BLANZ, J., OBERMAIER, C. D., STROJNY, C., 
SAVAS, J. N., KISKINIS, E., ZHUANG, X., KRUGER, R., SURMEIER, D. J. 
& KRAINC, D. 2017. Dopamine oxidation mediates mitochondrial and lysosomal 
dysfunction in Parkinson's disease. Science, 357, 1255-1261. 
CARLESS, M. A., GLAHN, D. C., JOHNSON, M. P., CURRAN, J. E., 
BOZAOGLU, K., DYER, T. D., WINKLER, A. M., COLE, S. A., ALMASY, L., 
MACCLUER, J. W., DUGGIRALA, R., MOSES, E. K., GORING, H. H. & 
BLANGERO, J. 2011. Impact of DISC1 variation on neuroanatomical and 
neurocognitive phenotypes. Mol Psychiatry, 16, 1096-104, 1063. 
CARROLL, C. A., BOGGS, J., O'DONNELL, B. F., SHEKHAR, A. & 
HETRICK, W. P. 2008. Temporal processing dysfunction in schizophrenia. Brain 
Cogn, 67, 150-61. 
CASTILLO-GOMEZ, E., VAREA, E., BLASCO-IBANEZ, J. M., CRESPO, C. 
& NACHER, J. 2016. Effects of Chronic Dopamine D2R Agonist Treatment and 
Polysialic Acid Depletion on Dendritic Spine Density and Excitatory 
Neurotransmission in the mPFC of Adult Rats. Neural Plast, 2016, 1615363. 
147 
 
CHARVIN, D., VANHOUTTE, P., PAGES, C., BORRELLI, E. & CABOCHE, 
J. 2005. Unraveling a role for dopamine in Huntington's disease: the dual role of 
reactive oxygen species and D2 receptor stimulation. Proc Natl Acad Sci U S A, 
102, 12218-23. 
CHEN, S., OWENS, G. C. & EDELMAN, D. B. 2008. Dopamine inhibits 
mitochondrial motility in hippocampal neurons. PLoS One, 3, e2804. 
CLAPCOTE, S. J., LIPINA, T. V., MILLAR, J. K., MACKIE, S., CHRISTIE, S., 
OGAWA, F., LERCH, J. P., TRIMBLE, K., UCHIYAMA, M., SAKURABA, Y., 
KANEDA, H., SHIROISHI, T., HOUSLAY, M. D., HENKELMAN, R. M., 
SLED, J. G., GONDO, Y., PORTEOUS, D. J. & RODER, J. C. 2007. Behavioral 
phenotypes of Disc1 missense mutations in mice. Neuron, 54, 387-402. 
CLINTON, S. M. & MEADOR-WOODRUFF, J. H. 2004. Abnormalities of the 
NMDA Receptor and Associated Intracellular Molecules in the Thalamus in 
Schizophrenia and Bipolar Disorder. Neuropsychopharmacology, 29, 1353-62. 
DA LUZ, M. H., PERES, I. T., SANTOS, T. G., MARTINS, V. R., ICIMOTO, 
M. Y. & LEE, K. S. 2015. Dopamine induces the accumulation of insoluble prion 
protein and affects autophagic flux. Front Cell Neurosci, 9, 12. 
DE BARTOLOMEIS, A., LATTE, G., TOMASETTI, C. & IASEVOLI, F. 2014. 
Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and 
dendritic spines morphology: relevance to schizophrenia and other behavioral 
disorders pathophysiology, and implications for novel therapeutic approaches. 
Mol Neurobiol, 49, 484-511. 
DE BARTOLOMEIS, A., TOMASETTI, C. & IASEVOLI, F. 2015. Update on 
the Mechanism of Action of Aripiprazole: Translational Insights into 
148 
 
Antipsychotic Strategies Beyond Dopamine Receptor Antagonism. CNS Drugs, 
29, 773-99. 
DE MEI, C., RAMOS, M., IITAKA, C. & BORRELLI, E. 2009. Getting 
specialized: presynaptic and postsynaptic dopamine D2 receptors. Curr Opin 
Pharmacol, 9, 53-8. 
DELCAMBRE, S., NONNENMACHER, Y. & HILLER, K. 2016. Dopamine 
Metabolism and Reactive Oxygen Species Production. 25-47. 
DEVINE, M. J. & KITTLER, J. T. 2018. Mitochondria at the neuronal presynapse 
in health and disease. Nat Rev Neurosci, 19, 63-80. 
DIAS, V., JUNN, E. & MOURADIAN, M. M. 2013. The role of oxidative stress 
in Parkinson's disease. J Parkinsons Dis, 3, 461-91. 
DISEASE, G. B. D., INJURY, I. & PREVALENCE, C. 2018. Global, regional, 
and national incidence, prevalence, and years lived with disability for 354 diseases 
and injuries for 195 countries and territories, 1990-2017: a systematic analysis for 
the Global Burden of Disease Study 2017. Lancet, 392, 1789-1858. 
DU, W., SU, Q. P., CHEN, Y., ZHU, Y., JIANG, D., RONG, Y., ZHANG, S., 
ZHANG, Y., REN, H., ZHANG, C., WANG, X., GAO, N., WANG, Y., SUN, L., 
SUN, Y. & YU, L. 2016. Kinesin 1 Drives Autolysosome Tubulation. Dev Cell, 
37, 326-336. 
FANG, E. F., HOU, Y., PALIKARAS, K., ADRIAANSE, B. A., KERR, J. S., 
YANG, B., LAUTRUP, S., HASAN-OLIVE, M. M., CAPONIO, D., DAN, X., 
ROCKTASCHEL, P., CROTEAU, D. L., AKBARI, M., GREIG, N. H., 
FLADBY, T., NILSEN, H., CADER, M. Z., MATTSON, M. P., 
TAVERNARAKIS, N. & BOHR, V. A. 2019. Mitophagy inhibits amyloid-beta 
149 
 
and tau pathology and reverses cognitive deficits in models of Alzheimer's disease. 
Nat Neurosci, 22, 401-412. 
FUKUI, K. 2016. Reactive oxygen species induce neurite degeneration before 
induction of cell death. J Clin Biochem Nutr, 59, 155-159. 
GANDHI, S. & ABRAMOV, A. Y. 2012. Mechanism of oxidative stress in 
neurodegeneration. Oxid Med Cell Longev, 2012, 428010. 
GANJAM, G. K., BOLTE, K., MATSCHKE, L. A., NEITEMEIER, S., DOLGA, 
A. M., HOLLERHAGE, M., HOGLINGER, G. U., ADAMCZYK, A., DECHER, 
N., OERTEL, W. H. & CULMSEE, C. 2019. Mitochondrial damage by alpha-
synuclein causes cell death in human dopaminergic neurons. Cell Death Dis, 10, 
865. 
GASSO, P., MAS, S., MOLINA, O., BERNARDO, M., LAFUENTE, A. & 
PARELLADA, E. 2012. Neurotoxic/neuroprotective activity of haloperidol, 
risperidone and paliperidone in neuroblastoma cells. Prog 
Neuropsychopharmacol Biol Psychiatry, 36, 71-7. 
GIRGIS, R. R., MERRILL, D. B., VOREL, S. R., EDWARD, K., KIMBERLY, 
P., YOU, M., PIKALOV, A., WHITEHEAD, R. & LIEBERMAN, J. A. 2011. 
Aripiprazole versus haloperidol treatment in early-stage schizophrenia. J 
Psychiatr Res, 45, 756-62. 
GIROS, B., SOKOLOFF, P., MARTRES, M. P., RIOU, J. F., EMORINE, L. J. & 
SCHWARTZ, J. C. 1989. Alternative splicing directs the expression of two D2 
dopamine receptor isoforms. Nature, 342, 923-6. 
GLANTZ, L. A. & LEWIS, D. A. 2000. Decreased dendritic spine density on 




GOLD, J. M., BISH, J. A., IANNONE, V. N., HOBART, M. P., QUEERN, C. A. 
& BUCHANAN, R. W. 2000. Effects of contextual processing on visual 
conditional associative learning in schizophrenia. Biol Psychiatry, 48, 406-14. 
GOMES, F. V., RINCON-CORTES, M. & GRACE, A. A. 2016. Adolescence as 
a period of vulnerability and intervention in schizophrenia: Insights from the 
MAM model. Neurosci Biobehav Rev, 70, 260-270. 
GOMEZ-SANTOS, C., FERRER, I., SANTIDRIAN, A. F., BARRACHINA, M., 
GIL, J. & AMBROSIO, S. 2003. Dopamine induces autophagic cell death and 
alpha-synuclein increase in human neuroblastoma SH-SY5Y cells. J Neurosci Res, 
73, 341-50. 
GOTZSCHE, C. R. & WOLDBYE, D. P. 2016. The role of NPY in learning and 
memory. Neuropeptides, 55, 79-89. 
GRIMA, G. 2003. Dopamine-induced oxidative stress in neurons with glutathione 
deficit: implication for schizophrenia. Schizophrenia Research, 62, 213-224. 
GRIMES, C. A. & JOPE, R. S. 2001. The multifaceted roles of glycogen synthase 
kinase 3beta in cellular signaling. Prog Neurobiol, 65. 
HANSEL, D. E., EIPPER, B. A. & RONNETT, G. V. 2001. Neuropeptide Y 
functions as a neuroproliferative factor. Nature, 410, 940-944. 
HARRISON, P. J. & WEINBERGER, D. R. 2005. Schizophrenia genes, gene 
expression, and neuropathology: on the matter of their convergence. Mol 
Psychiatry, 10, 40-68; image 5. 
HARVEY, P. D., RABINOWITZ, J., EERDEKENS, M. & DAVIDSON, M. 2005. 
Treatment of cognitive impairment in early psychosis: a comparison of 




HASBI, A., FAN, T., ALIJANIARAM, M., NGUYEN, T., PERREAULT, M. L., 
O'DOWD, B. F. & GEORGE, S. R. 2009. Calcium signaling cascade links 
dopamine D1-D2 receptor heteromer to striatal BDNF production and neuronal 
growth. Proc Natl Acad Sci U S A, 106, 21377-82. 
HAYASHI-TAKAGI, A., TAKAKI, M., GRAZIANE, N., SESHADRI, S., 
MURDOCH, H., DUNLOP, A. J., MAKINO, Y., SESHADRI, A. J., ISHIZUKA, 
K., SRIVASTAVA, D. P., XIE, Z., BARABAN, J. M., HOUSLAY, M. D., 
TOMODA, T., BRANDON, N. J., KAMIYA, A., YAN, Z., PENZES, P. & 
SAWA, A. 2010. Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the 
glutamate synapse via Rac1. Nat Neurosci, 13, 327-32. 
HE, W. Y., ZHANG, B., ZHAO, W. C., HE, J., ZHANG, L., XIONG, Q. M., 
WANG, J. & WANG, H. B. 2019. Contributions of mTOR Activation-Mediated 
Upregulation of Synapsin II and Neurite Outgrowth to Hyperalgesia in STZ-
Induced Diabetic Rats. ACS Chem Neurosci, 10, 2385-2396. 
HERVERA, A., DE VIRGILIIS, F., PALMISANO, I., ZHOU, L., TANTARDINI, 
E., KONG, G., HUTSON, T., DANZI, M. C., PERRY, R. B., SANTOS, C. X. C., 
KAPUSTIN, A. N., FLECK, R. A., DEL RIO, J. A., CARROLL, T., LEMMON, 
V., BIXBY, J. L., SHAH, A. M., FAINZILBER, M. & DI GIOVANNI, S. 2018. 
Reactive oxygen species regulate axonal regeneration through the release of 
exosomal NADPH oxidase 2 complexes into injured axons. Nat Cell Biol, 20, 
307-319. 
HOWES, O. D. & KAPUR, S. 2009. The dopamine hypothesis of schizophrenia: 
version III--the final common pathway. Schizophr Bull, 35, 549-62. 
152 
 
HOWES, O. D., MCCUTCHEON, R., OWEN, M. J. & MURRAY, R. 2016. The 
role of genes, stress and dopamine in the development of schizophrenia. 
Biological Psychiatry. 
HOWES, O. D., MONTGOMERY, A. J., ASSELIN, M. C., MURRAY, R. M., 
VALLI, I., TABRAHAM, P., BRAMON-BOSCH, E., VALMAGGIA, L., 
JOHNS, L., BROOME, M., MCGUIRE, P. K. & GRASBY, P. M. 2009. Elevated 
striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen 
Psychiatry, 66, 13-20. 
HRUSKA, M., HENDERSON, N., LE MARCHAND, S. J., JAFRI, H. & 
DALVA, M. B. 2018. Synaptic nanomodules underlie the organization and 
plasticity of spine synapses. Nat Neurosci, 21, 671-682. 
HU, M., ZHENG, P., XIE, Y., BOZ, Z., YU, Y., TANG, R., JONES, A., ZHENG, 
K. & HUANG, X. F. 2018. Propionate Protects Haloperidol-Induced Neurite 
Lesions Mediated by Neuropeptide Y. Front Neurosci, 12, 743. 
HUANG, X. F., DENG, C. & ZAVITSANOU, K. 2006. Neuropeptide Y mRNA 
expression levels following chronic olanzapine, clozapine and haloperidol 
administration in rats. Neuropeptides, 40, 213-9. 
HUANG, X. F. & SONG, X. 2019. Effects of antipsychotic drugs on neurites 
relevant to schizophrenia treatment. Med Res Rev, 39, 386-403. 
HURLEY, M. J. & JENNER, P. 2006. What has been learnt from study of 
dopamine receptors in Parkinson's disease? Pharmacol Ther, 111, 715-28. 
ISHIMA, T., FUTAMURA, T., OHGI, Y., YOSHIMI, N., KIKUCHI, T. & 
HASHIMOTO, K. 2015. Potentiation of neurite outgrowth by brexpiprazole, a 
novel serotonin-dopamine activity modulator: a role for serotonin 5-HT1A and 5-
HT2A receptors. Eur Neuropsychopharmacol, 25, 505-11. 
153 
 
ISHIMA, T., IYO, M. & HASHIMOTO, K. 2012. Neurite outgrowth mediated by 
the heat shock protein Hsp90alpha: a novel target for the antipsychotic drug 
aripiprazole. Transl Psychiatry, 2, e170. 
ISHIZUKA, K., PAEK, M., KAMIYA, A. & SAWA, A. 2006. A review of 
Disrupted-In-Schizophrenia-1 (DISC1): neurodevelopment, cognition, and 
mental conditions. Biol Psychiatry, 59, 1189-97. 
ITOH, K., NAKAMURA, K., IIJIMA, M. & SESAKI, H. 2013. Mitochondrial 
dynamics in neurodegeneration. Trends Cell Biol, 23, 64-71. 
JAARO-PELED, H., NIWA, M., FOSS, C. A., MURAI, R., DE LOS REYES, S., 
KAMIYA, A., MATEO, Y., O'DONNELL, P., CASCELLA, N. G., 
NABESHIMA, T., GUILARTE, T. R., POMPER, M. G. & SAWA, A. 2013. 
Subcortical dopaminergic deficits in a DISC1 mutant model: a study in direct 
reference to human molecular brain imaging. Hum Mol Genet, 22, 1574-80. 
JEZEK, J., COOPER, K. F. & STRICH, R. 2018. Reactive Oxygen Species and 
Mitochondrial Dynamics: The Yin and Yang of Mitochondrial Dysfunction and 
Cancer Progression. Antioxidants (Basel), 7. 
JIA, J. M., ZHAO, J., HU, Z., LINDBERG, D. & LI, Z. 2013. Age-dependent 
regulation of synaptic connections by dopamine D2 receptors. Nat Neurosci, 16, 
1627-36. 
JONG, Y. I., HARMON, S. K. & O'MALLEY, K. L. 2018. GPCR signalling from 
within the cell. Br J Pharmacol, 175, 4026-4035. 
JORDAN, W., DOBROWOLNY, H., BAHN, S., BERNSTEIN, H. G., 
BRIGADSKI, T., FRODL, T., ISERMANN, B., LESSMANN, V., PILZ, J., 
RODENBECK, A., SCHILTZ, K., SCHWEDHELM, E., TUMANI, H., 
WILTFANG, J., GUEST, P. C. & STEINER, J. 2018. Oxidative stress in drug-
154 
 
naive first episode patients with schizophrenia and major depression: effects of 
disease acuity and potential confounders. Eur Arch Psychiatry Clin Neurosci, 268, 
129-143. 
KAIDANOVICH-BEILIN, O., LIPINA, T. V., TAKAO, K., VAN EEDE, M., 
HATTORI, S., LALIBERTÉ, C., KHAN, M., OKAMOTO, K., CHAMBERS, J. 
W., FLETCHER, P. J., MACAULAY, K., DOBLE, B. W., HENKELMAN, M., 
MIYAKAWA, T., RODER, J. & WOODGETT, J. R. 2009. Abnormalities in 
brain structure and behavior in GSK-3alpha mutant mice. Molecular Brain, 2, 35. 
KANE, J. M., CARSON, W. H., SAHA, A. R., MCQUADE, R. D., INGENITO, 
G. G., ZIMBROFF, D. L. & ALI, M. W. 2002. Efficacy and safety of aripiprazole 
and haloperidol versus placebo in patients with schizophrenia and schizoaffective 
disorder. J Clin Psychiatry, 63, 763-71. 
KANE, J. M., MELTZER, H. Y., CARSON, W. H., JR., MCQUADE, R. D., 
MARCUS, R. N., SANCHEZ, R. & ARIPIPRAZOLE STUDY, G. 2007. 
Aripiprazole for treatment-resistant schizophrenia: results of a multicenter, 
randomized, double-blind, comparison study versus perphenazine. J Clin 
Psychiatry, 68, 213-23. 
KAPUR, S. & MARQUES, T. R. 2016. Dopamine, Striatum, Antipsychotics, and 
Questions About Weight Gain. JAMA Psychiatry, 73, 107-8. 
KAPUR, S., ZIPURSKY, R., JONES, C., REMINGTON, G. & HOULE, S. 2000. 
Relationship between dopamine D-2 occupancy, clinical response, and side 
effects: A double-blind PET study of first-episode schizophrenia. American 
Journal of Psychiatry, 157, 514-520. 
KARL, T. & ARNOLD, J. C. 2014. Schizophrenia: a consequence of gene-
environment interactions? Front Behav Neurosci, 8, 435. 
155 
 
KEGELES, L. S., SLIFSTEIN, M., FRANKLE, W. G., XU, X., HACKETT, E., 
BAE, S. A., GONZALES, R., KIM, J. H., ALVAREZ, B., GIL, R., LARUELLE, 
M. & ABI-DARGHAM, A. 2008. Dose-occupancy study of striatal and 
extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET 
and [18F]fallypride. Neuropsychopharmacology, 33, 3111-25. 
KELLENDONK, C., SIMPSON, E. H., POLAN, H. J., MALLERET, G., 
VRONSKAYA, S., WINIGER, V., MOORE, H. & KANDEL, E. R. 2006. 
Transient and Selective Overexpression of Dopamine D2 Receptors in the 
Striatum Causes Persistent Abnormalities in Prefrontal Cortex Functioning. 
Neuron, 49, 603-615. 
KELLY, M. A., RUBINSTEIN, M., PHILLIPS, T. J., LESSOV, C. N., 
BURKHART-KASCH, S., ZHANG, G., BUNZOW, J. R., FANG, Y., 
GERHARDT, G. A., GRANDY, D. K. & LOW, M. J. 1998. Locomotor activity 
in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic 
background, and developmental adaptations. J Neurosci, 18, 3470-9. 
KESBY, J. P., EYLES, D. W., MCGRATH, J. J. & SCOTT, J. G. 2018. Dopamine, 
psychosis and schizophrenia: the widening gap between basic and clinical 
neuroscience. Transl Psychiatry, 8, 30. 
KIM, J. Y., DUAN, X., LIU, C. Y., JANG, M. H., GUO, J. U., POW-
ANPONGKUL, N., KANG, E., SONG, H. & MING, G. L. 2009. DISC1 regulates 
new neuron development in the adult brain via modulation of AKT-mTOR 
signaling through KIAA1212. Neuron, 63, 761-73. 
KIM, J. Y., LIU, C. Y., ZHANG, F., DUAN, X., WEN, Z., SONG, J., FEIGHERY, 
E., LU, B., RUJESCU, D., ST CLAIR, D., CHRISTIAN, K., CALLICOTT, J. H., 
WEINBERGER, D. R., SONG, H. & MING, G. L. 2012. Interplay between 
156 
 
DISC1 and GABA signaling regulates neurogenesis in mice and risk for 
schizophrenia. Cell, 148, 1051-64. 
KLEIN, M. O., BATTAGELLO, D. S., CARDOSO, A. R., HAUSER, D. N., 
BITTENCOURT, J. C. & CORREA, R. G. 2019. Dopamine: Functions, Signaling, 
and Association with Neurological Diseases. Cell Mol Neurobiol, 39, 31-59. 
KLIONSKY, D. J. & EMR, S. D. 2000. Cell biology - Autophagy as a regulated 
pathway of cellular degradation. Science, 290, 1717-1721. 
KOGA, M., SERRITELLA, A. V., SAWA, A. & SEDLAK, T. W. 2016. 
Implications for reactive oxygen species in schizophrenia pathogenesis. Schizophr 
Res, 176, 52-71. 
KOSTRZEWA, R. M., NOWAK, P., BRUS, R. & BROWN, R. W. 2016. 
Perinatal Treatments with the Dopamine D(2)-Receptor Agonist Quinpirole 
Produces Permanent D(2)-Receptor Supersensitization: a Model of Schizophrenia. 
Neurochem Res, 41, 183-92. 
KOSTRZEWA, R. M., WYDRA, K., FILIP, M., CRAWFORD, C. A., 
MCDOUGALL, S. A., BROWN, R. W., BORROTO-ESCUELA, D. O., FUXE, 
K. & GAINETDINOV, R. R. 2018. Dopamine D2 Receptor Supersensitivity as a 
Spectrum of Neurotoxicity and Status in Psychiatric Disorders. J Pharmacol Exp 
Ther, 366, 519-526. 
KOVACIC, P. & COOKSY, A. L. 2005. Unifying mechanism for toxicity and 
addiction by abused drugs: electron transfer and reactive oxygen species. Med 
Hypotheses, 64, 357-66. 
KUBOTA, M., NAGASHIMA, T., TAKANO, H., KODAKA, F., FUJIWARA, 
H., TAKAHATA, K., MORIGUCHI, S., KIMURA, Y., HIGUCHI, M., OKUBO, 
Y., TAKAHASHI, H., ITO, H. & SUHARA, T. 2017. Affinity States of Striatal 
157 
 
Dopamine D2 Receptors in Antipsychotic-Free Patients with Schizophrenia. Int J 
Neuropsychopharmacol, 20, 928-935. 
KUMAR, P. B. S., PANDEY, R. S., THIRTHALLI, J., KUMAR, P. T. S. & 
KUMAR, C. N. 2017. A Comparative Study of Short Term Efficacy of 
Aripiprazole and Risperidone in Schizophrenia. Curr Neuropharmacol, 15, 1073-
1084. 
KUO, D. Y. 2003. Further evidence for the mediation of both subtypes of 
dopamine D1/D2 receptors and cerebral neuropeptide Y (NPY) in amphetamine-
induced appetite suppression. Behav Brain Res, 147, 149-55. 
LANE, D. A., CHAN, J., FITZGERALD, M. L., KEARN, C. S., MACKIE, K. & 
PICKEL, V. M. 2012. Quinpirole elicits differential in vivo changes in the pre- 
and postsynaptic distributions of dopamine D(2) receptors in mouse striatum: 
relation to cannabinoid-1 (CB(1)) receptor targeting. Psychopharmacology (Berl), 
221, 101-13. 
LARSEN, K. B., LAMARK, T., OVERVATN, A., HARNESHAUG, I., 
JOHANSEN, T. & BJORKOY, G. 2010. A reporter cell system to monitor 
autophagy based on p62/SQSTM1. Autophagy, 6, 784-93. 
LEBEL, M., PATENAUDE, C., ALLYSON, J., MASSICOTTE, G. & CYR, M. 
2009. Dopamine D1 receptor activation induces tau phosphorylation via cdk5 and 
GSK3 signaling pathways. Neuropharmacology, 57, 392-402. 
LEE, F. H., FADEL, M. P., PRESTON-MAHER, K., CORDES, S. P., 
CLAPCOTE, S. J., PRICE, D. J., RODER, J. C. & WONG, A. H. 2011. Disc1 




LENG, Z. G., LIN, S. J., WU, Z. R., GUO, Y. H., CAI, L., SHANG, H. B., TANG, 
H., XUE, Y. J., LOU, M. Q., ZHAO, W., LE, W. D., ZHAO, W. G., ZHANG, X. 
& WU, Z. B. 2017. Activation of DRD5 (dopamine receptor D5) inhibits tumor 
growth by autophagic cell death. Autophagy, 13, 1404-1419. 
LI, X. M. & XU, H. 2007. Evidence for Neuroprotective Effects of Antipsychotic 
Drugs: Implications for the Pathophysiology and Treatment of Schizophrenia. 77, 
107-142. 
LIAN, J., HUANG, X. F., PAI, N. & DENG, C. 2014. Betahistine ameliorates 
olanzapine-induced weight gain through modulation of histaminergic, NPY and 
AMPK pathways. Psychoneuroendocrinology, 48, 77-86. 
LIEBERMAN, J. A., BYMASTER, F. P., MELTZER, H. Y., DEUTCH, A. Y., 
DUNCAN, G. E., MARX, C. E., APRILLE, J. R., DWYER, D. S., LI, X. M., 
MAHADIK, S. P., DUMAN, R. S., PORTER, J. H., MODICA-NAPOLITANO, 
J. S., NEWTON, S. S. & CSERNANSKY, J. G. 2008. Antipsychotic drugs: 
comparison in animal models of efficacy, neurotransmitter regulation, and 
neuroprotection. Pharmacol Rev, 60, 358-403. 
LIPINA, T. V., BEREGOVOY, N. A., TKACHENKO, A. A., PETROVA, E. S., 
STAROSTINA, M. V., ZHOU, Q. & LI, S. 2018. Uncoupling DISC1 x D2R 
Protein-Protein Interactions Facilitates Latent Inhibition in Disc1-L100P Animal 
Model of Schizophrenia and Enhances Synaptic Plasticity via D2 Receptors. 
Front Synaptic Neurosci, 10, 31. 
LIPINA, T. V., FLETCHER, P. J., LEE, F. H., WONG, A. H. & RODER, J. C. 
2013. Disrupted-in-schizophrenia-1 Gln31Leu polymorphism results in social 
anhedonia associated with monoaminergic imbalance and reduction of CREB and 
159 
 
beta-arrestin-1,2 in the nucleus accumbens in a mouse model of depression. 
Neuropsychopharmacology, 38, 423-36. 
LIPINA, T. V., KAIDANOVICH-BEILIN, O., PATEL, S., WANG, M., 
CLAPCOTE, S. J., LIU, F., WOODGETT, J. R. & RODER, J. C. 2011. Genetic 
and pharmacological evidence for schizophrenia-related Disc1 interaction with 
GSK-3. Synapse, 65, 234-48. 
LIU, W. J., YE, L., HUANG, W. F., GUO, L. J., XU, Z. G., WU, H. L., YANG, 
C. & LIU, H. F. 2016. p62 links the autophagy pathway and the ubiqutin-
proteasome system upon ubiquitinated protein degradation. Cell Mol Biol Lett, 21, 
29. 
LOU, G., PALIKARAS, K., LAUTRUP, S., SCHEIBYE-KNUDSEN, M., 
TAVERNARAKIS, N. & FANG, E. F. 2019. Mitophagy and Neuroprotection. 
Trends Mol Med. 
LOVESTONE, S., KILLICK, R., DI FORTI, M. & MURRAY, R. 2007. 
Schizophrenia as a GSK-3 dysregulation disorder. Trends Neurosci, 30, 142-9. 
MACDONALD, M. L., ALHASSAN, J., NEWMAN, J. T., RICHARD, M., GU, 
H., KELLY, R. M., SAMPSON, A. R., FISH, K. N., PENZES, P., WILLS, Z. P., 
LEWIS, D. A. & SWEET, R. A. 2017. Selective Loss of Smaller Spines in 
Schizophrenia. Am J Psychiatry, 174, 586-594. 
MAO, Y., GE, X., FRANK, C. L., MADISON, J. M., KOEHLER, A. N., DOUD, 
M. K., TASSA, C., BERRY, E. M., SODA, T., SINGH, K. K., BIECHELE, T., 
PETRYSHEN, T. L., MOON, R. T., HAGGARTY, S. J. & TSAI, L. H. 2009. 
Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via 
modulation of GSK3beta/beta-catenin signaling. Cell, 136, 1017-31. 
160 
 
MASRI, B., SALAHPOUR, A., DIDRIKSEN, M., GHISI, V., BEAULIEU, J. M., 
GAINETDINOV, R. R. & CARON, M. G. 2008. Antagonism of dopamine D2 
receptor/beta-arrestin 2 interaction is a common property of clinically effective 
antipsychotics. Proc Natl Acad Sci U S A, 105, 13656-61. 
MASSAAD, C. A. & KLANN, E. 2011. Reactive oxygen species in the regulation 
of synaptic plasticity and memory. Antioxid Redox Signal, 14, 2013-54. 
MATSUO, T., IZUMI, Y., KUME, T., TAKADA-TAKATORI, Y., SAWADA, 
H. & AKAIKE, A. 2010. Protective effect of aripiprazole against glutamate 
cytotoxicity in dopaminergic neurons of rat mesencephalic cultures. Neurosci Lett, 
481, 78-81. 
MERKWIRTH, C., MARTINELLI, P., KORWITZ, A., MORBIN, M., 
BRONNEKE, H. S., JORDAN, S. D., RUGARLI, E. I. & LANGER, T. 2012. 
Loss of prohibitin membrane scaffolds impairs mitochondrial architecture and 
leads to tau hyperphosphorylation and neurodegeneration. PLoS Genet, 8, 
e1003021. 
MILLAR, J. K., WILSON-ANNAN, J. C., ANDERSON, S., CHRISTIE, S., 
TAYLOR, M. S., SEMPLE, C. A., DEVON, R. S., ST CLAIR, D. M., MUIR, W. 
J., BLACKWOOD, D. H. & PORTEOUS, D. J. 2000. Disruption of two novel 
genes by a translocation co-segregating with schizophrenia. Hum Mol Genet, 9, 
1415-23. 
MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M. & CARON, M. G. 




MOLTENI, R., CALABRESE, F., RACAGNI, G., FUMAGALLI, F. & RIVA, 
M. A. 2009. Antipsychotic drug actions on gene modulation and signaling 
mechanisms. Pharmacol Ther, 124, 74-85. 
MOYER, C. E., SHELTON, M. A. & SWEET, R. A. 2015. Dendritic spine 
alterations in schizophrenia. Neurosci Lett, 601, 46-53. 
MUESER, K. T., DEAVERS, F., PENN, D. L. & CASSISI, J. E. 2013. 
Psychosocial treatments for schizophrenia. Annu Rev Clin Psychol, 9, 465-97. 
MURPHY, M. P. 2009. How mitochondria produce reactive oxygen species. 
Biochem J, 417, 1-13. 
NIWA, M., KAMIYA, A., MURAI, R., KUBO, K., GRUBER, A. J., TOMITA, 
K., LU, L., TOMISATO, S., JAARO-PELED, H., SESHADRI, S., HIYAMA, H., 
HUANG, B., KOHDA, K., NODA, Y., O'DONNELL, P., NAKAJIMA, K., 
SAWA, A. & NABESHIMA, T. 2010. Knockdown of DISC1 by in utero gene 
transfer disturbs postnatal dopaminergic maturation in the frontal cortex and leads 
to adult behavioral deficits. Neuron, 65, 480-9. 
OKABE, S., MIWA, A. & OKADO, H. 2001. Spine formation and correlated 
assembly of presynaptic and postsynaptic molecules. J Neurosci, 21, 6105-14. 
ONISHI, T., SAKAMOTO, H., NAMIKI, S. & HIROSE, K. 2018. The Altered 
Supramolecular Structure of Dopamine D2 Receptors in Disc1-deficient Mice. Sci 
Rep, 8, 1692. 
OSIMO, E. F., BECK, K., REIS MARQUES, T. & HOWES, O. D. 2019. Synaptic 
loss in schizophrenia: a meta-analysis and systematic review of synaptic protein 
and mRNA measures. Mol Psychiatry, 24, 549-561. 
162 
 
PAN, B., HUANG, X. F. & DENG, C. 2016. Chronic administration of 
aripiprazole activates GSK3beta-dependent signalling pathways, and up-regulates 
GABAA receptor expression and CREB1 activity in rats. Sci Rep, 6, 30040. 
PARK, S. W., LEE, C. H., CHO, H. Y., SEO, M. K., LEE, J. G., LEE, B. J., SEOL, 
W., KEE, B. S. & KIM, Y. H. 2013. Effects of antipsychotic drugs on the 
expression of synaptic proteins and dendritic outgrowth in hippocampal neuronal 
cultures. Synapse, 67, 224-34. 
PARK, S. W., LEE, J. G., HA, E. K., CHOI, S. M., CHO, H. Y., SEO, M. K. & 
KIM, Y. H. 2009. Differential effects of aripiprazole and haloperidol on BDNF-
mediated signal changes in SH-SY5Y cells. Eur Neuropsychopharmacol, 19, 356-
62. 
PARK, S. W., PHUONG, V. T., LEE, C. H., LEE, J. G., SEO, M. K., CHO, H. 
Y., FANG, Z. H., LEE, B. J. & KIM, Y. H. 2011a. Effects of antipsychotic drugs 
on BDNF, GSK-3beta, and beta-catenin expression in rats subjected to 
immobilization stress. Neurosci Res, 71, 335-40. 
PARK, S. W., SEO, M. K., CHO, H. Y., LEE, J. G., LEE, B. J., SEOL, W. & 
KIM, Y. H. 2011b. Differential effects of amisulpride and haloperidol on 
dopamine D2 receptor-mediated signaling in SH-SY5Y cells. 
Neuropharmacology, 61, 761-9. 
PARRADO-FERNANDEZ, C., SCHNEIDER, B., ANKARCRONA, M., CONTI, 
M. M., COOKSON, M. R., KIVIPELTO, M., CEDAZO-MINGUEZ, A. & 
SANDEBRING-MATTON, A. 2018. Reduction of PINK1 or DJ-1 impair 
mitochondrial motility in neurites and alter ER-mitochondria contacts. J Cell Mol 
Med, 22, 5439-5449. 
163 
 
PRABAKARAN, S., SWATTON, J. E., RYAN, M. M., HUFFAKER, S. J., 
HUANG, J. T., GRIFFIN, J. L., WAYLAND, M., FREEMAN, T., DUDBRIDGE, 
F., LILLEY, K. S., KARP, N. A., HESTER, S., TKACHEV, D., MIMMACK, M. 
L., YOLKEN, R. H., WEBSTER, M. J., TORREY, E. F. & BAHN, S. 2004. 
Mitochondrial dysfunction in schizophrenia: evidence for compromised brain 
metabolism and oxidative stress. Mol Psychiatry, 9, 684-97, 643. 
RAE, C. L., DAVIES, G., GARFINKEL, S. N., GABEL, M. C., DOWELL, N. 
G., CERCIGNANI, M., SETH, A. K., GREENWOOD, K. E., MEDFORD, N. & 
CRITCHLEY, H. D. 2017. Deficits in Neurite Density Underlie White Matter 
Structure Abnormalities in First-Episode Psychosis. Biol Psychiatry, 82, 716-725. 
RAJASEKARAN, A., VENKATASUBRAMANIAN, G., BERK, M. & 
DEBNATH, M. 2015. Mitochondrial dysfunction in schizophrenia: pathways, 
mechanisms and implications. Neurosci Biobehav Rev, 48, 10-21. 
RANGEL-BARAJAS, C., CORONEL, I. & FLORAN, B. 2015. Dopamine 
Receptors and Neurodegeneration. Aging Dis, 6, 349-68. 
RASHID, A. J., SO, C. H., KONG, M. M., FURTAK, T., EL-GHUNDI, M., 
CHENG, R., O'DOWD, B. F. & GEORGE, S. R. 2007. D1-D2 dopamine receptor 
heterooligomers with unique pharmacology are coupled to rapid activation of 
Gq/11 in the striatum. Proc Natl Acad Sci U S A, 104, 654-9. 
RASMUSSEN, S. A., ROSEBUSH, P. I. & MAZUREK, M. F. 2017. The 
Relationship Between Early Haloperidol Response and Associated 
Extrapyramidal Side Effects. J Clin Psychopharmacol, 37, 8-12. 
REINOSO, B. S., UNDIE, A. S. & LEVITT, P. 1996. Dopamine receptors 
mediate differential morphological effects on cerebral cortical neurons in vitro.pdf. 
Journal of Neuroscience Research, 43, 439-453. 
164 
 
RONAN, J. L., WU, W. & CRABTREE, G. R. 2013. From neural development 
to cognition: unexpected roles for chromatin. Nat Rev Genet, 14, 347-59. 
RUST, M. J., BATES, M. & ZHUANG, X. 2006. Sub-diffraction-limit imaging 
by stochastic optical reconstruction microscopy (STORM). Nat Methods, 3, 793-
5. 
SAKURAI, H., BIES, R. R., STROUP, S. T., KEEFE, R. S., RAJJI, T. K., 
SUZUKI, T., MAMO, D. C., POLLOCK, B. G., WATANABE, K., MIMURA, 
M. & UCHIDA, H. 2013. Dopamine D2 receptor occupancy and cognition in 
schizophrenia: analysis of the CATIE data. Schizophr Bull, 39, 564-74. 
SCHOFIELD, J. H. & SCHAFER, Z. T. 2020. Mitochondrial Reactive Oxygen 
Species and Mitophagy: A Complex and Nuanced Relationship. Antioxid Redox 
Signal. 
SEEMAN, P. 1987. Dopamine receptors and the dopamine hypothesis of 
schizophrenia. Synapse, 1, 133-52. 
SEEMAN, P. 2006. Targeting the dopamine D2 receptor in schizophrenia. Expert 
Opin Ther Targets, 10, 515-31. 
SEEMAN, P., SCHWARZ, J., CHEN, J. F., SZECHTMAN, H., PERREAULT, 
M., MCKNIGHT, G. S., RODER, J. C., QUIRION, R., BOKSA, P., 
SRIVASTAVA, L. K., YANAI, K., WEINSHENKER, D. & SUMIYOSHI, T. 
2006. Psychosis pathways converge via D2high dopamine receptors. Synapse, 60, 
319-46. 
SESHADRI, S., FAUST, T., ISHIZUKA, K., DELEVICH, K., CHUNG, Y., KIM, 
S. H., COWLES, M., NIWA, M., JAARO-PELED, H., TOMODA, T., LAI, C., 
ANTON, E. S., LI, B. & SAWA, A. 2015. Interneuronal DISC1 regulates NRG1-
165 
 
ErbB4 signalling and excitatory-inhibitory synapse formation in the mature cortex. 
Nat Commun, 6, 10118. 
SHAHANI, N., SESHADRI, S., JAARO-PELED, H., ISHIZUKA, K., HIROTA-
TSUYADA, Y., WANG, Q., KOGA, M., SEDLAK, T. W., KORTH, C., 
BRANDON, N. J., KAMIYA, A., SUBRAMANIAM, S., TOMODA, T. & 
SAWA, A. 2015. DISC1 regulates trafficking and processing of APP and Abeta 
generation. Mol Psychiatry, 20, 874-9. 
SHIN, S., KIM, S., SEO, S., LEE, J. S., HOWES, O. D., KIM, E. & KWON, J. S. 
2018. The relationship between dopamine receptor blockade and cognitive 
performance in schizophrenia: a [(11)C]-raclopride PET study with aripiprazole. 
Transl Psychiatry, 8, 87. 
SIEGMUND, S. E., GRASSUCCI, R., CARTER, S. D., BARCA, E., FARINO, 
Z. J., JUANOLA-FALGARONA, M., ZHANG, P., TANJI, K., HIRANO, M., 
SCHON, E. A., FRANK, J. & FREYBERG, Z. 2018. Three-Dimensional 
Analysis of Mitochondrial Crista Ultrastructure in a Patient with Leigh Syndrome 
by In Situ Cryoelectron Tomography. iScience, 6, 83-91. 
SIMPSON, E. H., KELLENDONK, C. & KANDEL, E. 2010. A possible role for 
the striatum in the pathogenesis of the cognitive symptoms of schizophrenia. 
Neuron, 65, 585-96. 
SINGH, K. K., DE RIENZO, G., DRANE, L., MAO, Y., FLOOD, Z., MADISON, 
J., FERREIRA, M., BERGEN, S., KING, C., SKLAR, P., SIVE, H. & TSAI, L. 
H. 2011. Common DISC1 polymorphisms disrupt Wnt/GSK3beta signaling and 
brain development. Neuron, 72, 545-58. 
166 
 
SOLBERG, D. K., REFSUM, H., ANDREASSEN, O. A. & BENTSEN, H. 2019. 
A five-year follow-up study of antioxidants, oxidative stress and polyunsaturated 
fatty acids in schizophrenia. Acta Neuropsychiatr, 31, 202-212. 
SOLIS, O., VAZQUEZ-ROQUE, R. A., CAMACHO-ABREGO, I., GAMBOA, 
C., DE LA CRUZ, F., ZAMUDIO, S. & FLORES, G. 2009. Decreased dendritic 
spine density of neurons of the prefrontal cortex and nucleus accumbens and 
enhanced amphetamine sensitivity in postpubertal rats after a neonatal amygdala 
lesion. Synapse, 63, 1143-53. 
SPERANZA, L., GIULIANO, T., VOLPICELLI, F., DE STEFANO, M. E., 
LOMBARDI, L., CHAMBERY, A., LACIVITA, E., LEOPOLDO, M., 
BELLENCHI, G. C., DI PORZIO, U., CRISPINO, M. & PERRONE-CAPANO, 
C. 2015. Activation of 5-HT7 receptor stimulates neurite elongation through 
mTOR, Cdc42 and actin filaments dynamics. Front Behav Neurosci, 9, 62. 
STUCHLIK, A., RADOSTOVA, D., HATALOVA, H., VALES, K., 
NEKOVAROVA, T., KOPRIVOVA, J., SVOBODA, J. & HORACEK, J. 2016. 
Validity of Quinpirole Sensitization Rat Model of OCD: Linking Evidence from 
Animal and Clinical Studies. Front Behav Neurosci, 10, 209. 
SU, P., LI, S., CHEN, S., LIPINA, T. V., WANG, M., LAI, T. K., LEE, F. H., 
ZHANG, H., ZHAI, D., FERGUSON, S. S., NOBREGA, J. N., WONG, A. H., 
RODER, J. C., FLETCHER, P. J. & LIU, F. 2014. A dopamine D2 receptor-
DISC1 protein complex may contribute to antipsychotic-like effects. Neuron, 84, 
1302-16. 
SU, S. H., WU, Y. F., WANG, D. P. & HAI, J. 2018. Inhibition of excessive 
autophagy and mitophagy mediates neuroprotective effects of URB597 against 
chronic cerebral hypoperfusion. Cell Death Dis, 9, 733. 
167 
 
SUMITOMO, A., HORIKE, K., HIRAI, K., BUTCHER, N., BOOT, E., 
SAKURAI, T., NUCIFORA, F. C., JR., BASSETT, A. S., SAWA, A. & 
TOMODA, T. 2018. A mouse model of 22q11.2 deletions: Molecular and 
behavioral signatures of Parkinson's disease and schizophrenia. Science advances, 
4, eaar6637-eaar6637. 
SUZUKAWA, K., MIURA, K., MITSUSHITA, J., RESAU, J., HIROSE, K., 
CRYSTAL, R. & KAMATA, T. 2000. Nerve growth factor-induced neuronal 
differentiation requires generation of Rac1-regulated reactive oxygen species. J 
Biol Chem, 275, 13175-8. 
SWARZENSKI, B. C., TANG, L., OH, Y. J., O'MALLEY, K. L. & TODD, R. D. 
1994. Morphogenic potentials of D2, D3, and D4 dopamine receptors revealed in 
transfected neuronal cell lines. Proc Natl Acad Sci U S A, 91, 649-53. 
TAKAKI, M., KODAMA, M., MIZUKI, Y., KAWAI, H., YOSHIMURA, B., 
KISHIMOTO, M., SAKAMOTO, S., OKAHISA, Y. & YAMADA, N. 2018. 
Effects of the antipsychotics haloperidol, clozapine, and aripiprazole on the 
dendritic spine. Eur Neuropsychopharmacol, 28, 610-619. 
TAO, C. L., LIU, Y. T., SUN, R., ZHANG, B., QI, L., SHIVAKOTI, S., TIAN, 
C. L., ZHANG, P., LAU, P. M., ZHOU, Z. H. & BI, G. Q. 2018. Differentiation 
and Characterization of Excitatory and Inhibitory Synapses by Cryo-electron 
Tomography and Correlative Microscopy. J Neurosci, 38, 1493-1510. 
TEK, C., GOLD, J., BLAXTON, T., WILK, C., MCMAHON, R. P. & 
BUCHANAN, R. W. 2002. Visual perceptual and working memory impairments 
in schizophrenia. Arch Gen Psychiatry, 59, 146-53. 
THUL, P. J., AKESSON, L., WIKING, M., MAHDESSIAN, D., GELADAKI, 
A., AIT BLAL, H., ALM, T., ASPLUND, A., BJORK, L., BRECKELS, L. M., 
168 
 
BACKSTROM, A., DANIELSSON, F., FAGERBERG, L., FALL, J., GATTO, 
L., GNANN, C., HOBER, S., HJELMARE, M., JOHANSSON, F., LEE, S., 
LINDSKOG, C., MULDER, J., MULVEY, C. M., NILSSON, P., OKSVOLD, P., 
ROCKBERG, J., SCHUTTEN, R., SCHWENK, J. M., SIVERTSSON, A., 
SJOSTEDT, E., SKOGS, M., STADLER, C., SULLIVAN, D. P., TEGEL, H., 
WINSNES, C., ZHANG, C., ZWAHLEN, M., MARDINOGLU, A., PONTEN, 
F., VON FEILITZEN, K., LILLEY, K. S., UHLEN, M. & LUNDBERG, E. 2017. 
A subcellular map of the human proteome. Science, 356. 
TODD, R. D. 1992. Neural Development Is Regulated by Classical 
Neurotransmitters - Dopamine D2 Receptor Stimulation Enhances Neurite 
Outgrowth. Biological Psychiatry, 31, 794-807. 
TOMODA, T., SUMITOMO, A., JAARO-PELED, H. & SAWA, A. 2016. Utility 
and validity of DISC1 mouse models in biological psychiatry. Neuroscience, 321, 
99-107. 
TOMODA, T., YANG, K. & SAWA, A. 2019. Neuronal Autophagy in Synaptic 
Functions and Psychiatric Disorders. Biol Psychiatry. 
TORO, C. & DEAKIN, J. F. 2005. NMDA receptor subunit NRI and postsynaptic 
protein PSD-95 in hippocampus and orbitofrontal cortex in schizophrenia and 
mood disorder. Schizophr Res, 80, 323-30. 
TRIGO, D., GONCALVES, M. B. & CORCORAN, J. P. T. 2019. The regulation 
of mitochondrial dynamics in neurite outgrowth by retinoic acid receptor beta 
signaling. FASEB J, 33, 7225-7235. 
TRIPATHI, P. P., SANTORUFO, G., BRILLI, E., BORRELLI, E. & BOZZI, Y. 
2010. Kainic acid-induced seizures activate GSK-3beta in the hippocampus of 
D2R-/- mice. Neuroreport, 21, 846-50. 
169 
 
TROSSBACH, S. V., BADER, V., HECHER, L., PUM, M. E., MASOUD, S. T., 
PRIKULIS, I., SCHABLE, S., DE SOUZA SILVA, M. A., SU, P., BOULAT, B., 
CHWIESKO, C., POSCHMANN, G., STUHLER, K., LOHR, K. M., STOUT, K. 
A., OSKAMP, A., GODSAVE, S. F., MULLER-SCHIFFMANN, A., BILZER, 
T., STEINER, H., PETERS, P. J., BAUER, A., SAUVAGE, M., RAMSEY, A. J., 
MILLER, G. W., LIU, F., SEEMAN, P., BRANDON, N. J., HUSTON, J. P. & 
KORTH, C. 2016. Misassembly of full-length Disrupted-in-Schizophrenia 1 
protein is linked to altered dopamine homeostasis and behavioral deficits. Mol 
Psychiatry. 
URS, N. M., PETERSON, S. M. & CARON, M. G. 2017. New Concepts in 
Dopamine D2 Receptor Biased Signaling and Implications for Schizophrenia 
Therapy. Biol Psychiatry, 81, 78-85. 
URS, N. M., SNYDER, J. C., JACOBSEN, J. P. R., PETERSON, S. M. & 
CARON, M. G. 2012. Deletion of GSK3β in D2R-expressing neurons reveals 
distinct roles for β-arrestin signaling in antipsychotic and lithium action. 
Proceedings of the National Academy of Sciences of the United States of America, 
109, 20732-20737. 
VIDONI, C., CASTIGLIONI, A., SECA, C., SECOMANDI, E., MELONE, M. 
A. & ISIDORO, C. 2016. Dopamine exacerbates mutant Huntingtin toxicity via 
oxidative-mediated inhibition of autophagy in SH-SY5Y neuroblastoma cells: 
Beneficial effects of anti-oxidant therapeutics. Neurochem Int, 101, 132-143. 
VITA, A., DE PERI, L., DESTE, G. & SACCHETTI, E. 2012. Progressive loss 
of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of 
longitudinal MRI studies. Transl Psychiatry, 2, e190. 
170 
 
WANG, D., JI, X., LIU, J., LI, Z. & ZHANG, X. 2018. Dopamine Receptor 
Subtypes Differentially Regulate Autophagy. Int J Mol Sci, 19. 
WANG, G., LI, Y., WANG, P., LIANG, H., CUI, M., ZHU, M., GUO, L., SU, 
Q., SUN, Y., MCNUTT, M. A. & YIN, Y. 2015. PTEN regulates RPA1 and 
protects DNA replication forks. Cell Res, 25, 1189-204. 
WANG, Q., ZHANG, H., XU, H., GUO, D., SHI, H., LI, Y., ZHANG, W. & GU, 
Y. 2016. 5-HTR3 and 5-HTR4 located on the mitochondrial membrane and 
functionally regulated mitochondrial functions. Sci Rep, 6, 37336. 
WANG, X., MENG, D., CHANG, Q., PAN, J., ZHANG, Z., CHEN, G., KE, Z., 
LUO, J. & SHI, X. 2010. Arsenic inhibits neurite outgrowth by inhibiting the 
LKB1-AMPK signaling pathway. Environ Health Perspect, 118, 627-34. 
WINTON-BROWN, T. T., FUSAR-POLI, P., UNGLESS, M. A. & HOWES, O. 
D. 2014. Dopaminergic basis of salience dysregulation in psychosis. Trends 
Neurosci, 37, 85-94. 
XIE, T., LI, Q., LUO, X., TIAN, L., WANG, Z., TAN, S., CHEN, S., YANG, G., 
AN, H., YANG, F. & TAN, Y. 2019. Plasma total antioxidant status and cognitive 
impairments in first-episode drug-naive patients with schizophrenia. Cogn 
Neurodyn, 13, 357-365. 
YAMADA, T., DAWSON, T. M., YANAGAWA, T., IIJIMA, M. & SESAKI, H. 
2019. SQSTM1/p62 promotes mitochondrial ubiquitination independently of 
PINK1 and PRKN/parkin in mitophagy. Autophagy, 15, 2012-2018. 
ZHANG, Q., YU, Y. & HUANG, X. F. 2016. Olanzapine Prevents the PCP-
induced Reduction in the Neurite Outgrowth of Prefrontal Cortical Neurons via 
NRG1. Sci Rep, 6, 19581. 
171 
 
ZHANG, X. Y. & YAO, J. K. 2013. Oxidative stress and therapeutic implications 
in psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry, 46, 197-9. 
ZHENG, P., HU, M., XIE, Y., YU, Y., JAARO-PELED, H. & HUANG, X. F. 
2018. Aripiprazole and haloperidol protect neurite lesions via reducing excessive 
D2R-DISC1 complex formation. Prog Neuropsychopharmacol Biol Psychiatry, 
92, 59-69. 
ZHOU, L. & TOO, H. P. 2011. Mitochondrial localized STAT3 is involved in 
NGF induced neurite outgrowth. PLoS One, 6, e21680. 
ZILOCCHI, M., FINZI, G., LUALDI, M., SESSA, F., FASANO, M. & 
ALBERIO, T. 2018. Mitochondrial alterations in Parkinson's disease human 
samples and cellular models. Neurochem Int, 118, 61-72. 
 
